At a glance

For Queensland residents admitted to Queensland public and private hospitals:

  • There were 2,857,614 admitted patient episodes of care in 2020–21.
  • The standardised hospitalisations rate was 507.4 per 1,000 persons (479.5 per 1,000 for males and 537.1 per 1,000 for females).
  • In the past two decades, age-standardised hospitalisation rates increased by 45% (350.1 to 507.4 per 1,000 persons in 2002–03 and 2020–21, respectively). This was driven by a 49% increase in adults 65 years and older (age-specific rate 946.0 and 1408.3 per 1,000 persons in 2002–03 and 2020–21, respectively). Increases varied by broad cause.
  • In 2020–21, the hospitalisation rate for adults 65 and older was 2.3 times higher than in 46 to 64 years olds (age-specific rate 1408.3 and 620.9 per 1,000 persons, respectively).
  • In remote and very remote areas, age-standardised hospitalisation rates were 22% higher than major cities (620.1 and 508.0 per 1,000 persons, respectively, in 2020–21). Age-standardised rates were 19% higher in the most disadvantaged compared to the most advantaged areas (564.2 and 473.7 per 1,000 persons, respectively, in 2020–21).

All cause hospitalisations

In 2020–21,

  • There were 2,857,614 admitted patient episodes of care in Queensland acute public and private hospitals by Queensland residents—53.3% were for females.
  • The age-standardised rate (ASR or standardised rate) was 507.4 per 1,000 for persons (537.1 for females and 479.5 for males). 1

Trends

Standardised hospitalisation rates increased by 44.9%—from 350.1 per 1,000 persons in 2002–03 to 507.4 per 1,000 persons (Figure 1).

  • Standardised rates increased every year except in 2019–20 when changes in admission practice and other public safety measures occurred in response to the COVID-19 pandemic.
  • Rates increased most in older age groups—the age-specific rate for people 65 years and older increased from 946.0 per 1,000 persons in 2002–03 to 1408.3 per 1,000 persons in 2020–21.

Figure 1: Queensland trends in all cause hospitalisation rate

Figure 1a: Queensland trends in all cause hospitalisation rates (age-standardised rate)
Line graph showing the trend of age-standardised rate of all cause hospitalisations by sex, showing increase in the hospitalisation rate since 2002--03
Figure 1b: Queensland trends in all cause hospitalisation rates (age-specific rate)

Line graph showing the trend of age-specific rate of all cause hospitalisations by sex, showing that the rate of increase is higher in older age group

Figure 1c: Queensland trends in all cause hospitalisation rates by age specific rate (table)

Ordered by age and sex

YearSex Age GroupType Rates (per 1,000 persons)
2002-03 Persons 0-14 Age Specific Rate 130.9
2003-04 Persons 0-14 Age Specific Rate 132.9
2004-05 Persons 0-14 Age Specific Rate 128.3
2005-06 Persons 0-14 Age Specific Rate 127.7
2006-07 Persons 0-14 Age Specific Rate 127.5
2007-08 Persons 0-14 Age Specific Rate 132.2
2008-09 Persons 0-14 Age Specific Rate 136.5
2009-10 Persons 0-14 Age Specific Rate 134.3
2010-11 Persons 0-14 Age Specific Rate 130.9
2011-12 Persons 0-14 Age Specific Rate 134.0
2012-13 Persons 0-14 Age Specific Rate 137.8
2013-14 Persons 0-14 Age Specific Rate 143.1
2014-15 Persons 0-14 Age Specific Rate 146.5
2015-16 Persons 0-14 Age Specific Rate 153.1
2016-17 Persons 0-14 Age Specific Rate 155.3
2017-18 Persons 0-14 Age Specific Rate 158.9
2018-19 Persons 0-14 Age Specific Rate 158.1
2019-20 Persons 0-14 Age Specific Rate 147.9
2020-21 Persons 0-14 Age Specific Rate 156.5
2002-03 Persons 15-29 Age Specific Rate 215.0
2003-04 Persons 15-29 Age Specific Rate 213.7
2004-05 Persons 15-29 Age Specific Rate 213.5
2005-06 Persons 15-29 Age Specific Rate 216.4
2006-07 Persons 15-29 Age Specific Rate 219.3
2007-08 Persons 15-29 Age Specific Rate 221.6
2008-09 Persons 15-29 Age Specific Rate 222.4
2009-10 Persons 15-29 Age Specific Rate 217.1
2010-11 Persons 15-29 Age Specific Rate 213.3
2011-12 Persons 15-29 Age Specific Rate 221.6
2012-13 Persons 15-29 Age Specific Rate 230.4
2013-14 Persons 15-29 Age Specific Rate 232.5
2014-15 Persons 15-29 Age Specific Rate 241.1
2015-16 Persons 15-29 Age Specific Rate 252.0
2016-17 Persons 15-29 Age Specific Rate 260.2
2017-18 Persons 15-29 Age Specific Rate 268.3
2018-19 Persons 15-29 Age Specific Rate 280.2
2019-20 Persons 15-29 Age Specific Rate 274.2
2020-21 Persons 15-29 Age Specific Rate 301.8
2002-03 Persons 30-44 Age Specific Rate 267.5
2003-04 Persons 30-44 Age Specific Rate 267.8
2004-05 Persons 30-44 Age Specific Rate 272.2
2005-06 Persons 30-44 Age Specific Rate 274.8
2006-07 Persons 30-44 Age Specific Rate 278.7
2007-08 Persons 30-44 Age Specific Rate 284.5
2008-09 Persons 30-44 Age Specific Rate 290.5
2009-10 Persons 30-44 Age Specific Rate 294.5
2010-11 Persons 30-44 Age Specific Rate 293.9
2011-12 Persons 30-44 Age Specific Rate 300.4
2012-13 Persons 30-44 Age Specific Rate 310.7
2013-14 Persons 30-44 Age Specific Rate 319.0
2014-15 Persons 30-44 Age Specific Rate 331.4
2015-16 Persons 30-44 Age Specific Rate 346.2
2016-17 Persons 30-44 Age Specific Rate 360.2
2017-18 Persons 30-44 Age Specific Rate 369.9
2018-19 Persons 30-44 Age Specific Rate 382.7
2019-20 Persons 30-44 Age Specific Rate 377.9
2020-21 Persons 30-44 Age Specific Rate 410.6
2002-03 Persons 45-64 Age Specific Rate 425.2
2003-04 Persons 45-64 Age Specific Rate 426.4
2004-05 Persons 45-64 Age Specific Rate 427.0
2005-06 Persons 45-64 Age Specific Rate 431.2
2006-07 Persons 45-64 Age Specific Rate 441.8
2007-08 Persons 45-64 Age Specific Rate 457.8
2008-09 Persons 45-64 Age Specific Rate 468.8
2009-10 Persons 45-64 Age Specific Rate 477.1
2010-11 Persons 45-64 Age Specific Rate 482.5
2011-12 Persons 45-64 Age Specific Rate 484.9
2012-13 Persons 45-64 Age Specific Rate 484.6
2013-14 Persons 45-64 Age Specific Rate 500.6
2014-15 Persons 45-64 Age Specific Rate 533.1
2015-16 Persons 45-64 Age Specific Rate 549.8
2016-17 Persons 45-64 Age Specific Rate 568.5
2017-18 Persons 45-64 Age Specific Rate 588.6
2018-19 Persons 45-64 Age Specific Rate 597.5
2019-20 Persons 45-64 Age Specific Rate 589.0
2020-21 Persons 45-64 Age Specific Rate 620.9
2002-03 Persons 65+ Age Specific Rate 946.0
2003-04 Persons 65+ Age Specific Rate 985.1
2004-05 Persons 65+ Age Specific Rate 1,013.1
2005-06 Persons 65+ Age Specific Rate 1,024.8
2006-07 Persons 65+ Age Specific Rate 1,045.8
2007-08 Persons 65+ Age Specific Rate 1,073.2
2008-09 Persons 65+ Age Specific Rate 1,109.6
2009-10 Persons 65+ Age Specific Rate 1,138.8
2010-11 Persons 65+ Age Specific Rate 1,163.6
2011-12 Persons 65+ Age Specific Rate 1,190.0
2012-13 Persons 65+ Age Specific Rate 1,193.5
2013-14 Persons 65+ Age Specific Rate 1,206.4
2014-15 Persons 65+ Age Specific Rate 1,289.8
2015-16 Persons 65+ Age Specific Rate 1,329.3
2016-17 Persons 65+ Age Specific Rate 1,368.8
2017-18 Persons 65+ Age Specific Rate 1,393.6
2018-19 Persons 65+ Age Specific Rate 1,408.4
2019-20 Persons 65+ Age Specific Rate 1,367.9
2020-21 Persons 65+ Age Specific Rate 1,408.3
2002-03 Males 0-14 Age Specific Rate 147.4
2003-04 Males 0-14 Age Specific Rate 150.4
2004-05 Males 0-14 Age Specific Rate 145.1
2005-06 Males 0-14 Age Specific Rate 142.3
2006-07 Males 0-14 Age Specific Rate 142.3
2007-08 Males 0-14 Age Specific Rate 148.5
2008-09 Males 0-14 Age Specific Rate 152.1
2009-10 Males 0-14 Age Specific Rate 150.2
2010-11 Males 0-14 Age Specific Rate 144.6
2011-12 Males 0-14 Age Specific Rate 149.2
2012-13 Males 0-14 Age Specific Rate 154.1
2013-14 Males 0-14 Age Specific Rate 159.2
2014-15 Males 0-14 Age Specific Rate 161.9
2015-16 Males 0-14 Age Specific Rate 169.6
2016-17 Males 0-14 Age Specific Rate 172.9
2017-18 Males 0-14 Age Specific Rate 174.9
2018-19 Males 0-14 Age Specific Rate 174.5
2019-20 Males 0-14 Age Specific Rate 162.5
2020-21 Males 0-14 Age Specific Rate 170.7
2002-03 Males 15-29 Age Specific Rate 141.9
2003-04 Males 15-29 Age Specific Rate 139.8
2004-05 Males 15-29 Age Specific Rate 136.0
2005-06 Males 15-29 Age Specific Rate 136.9
2006-07 Males 15-29 Age Specific Rate 139.6
2007-08 Males 15-29 Age Specific Rate 142.0
2008-09 Males 15-29 Age Specific Rate 145.0
2009-10 Males 15-29 Age Specific Rate 140.2
2010-11 Males 15-29 Age Specific Rate 137.4
2011-12 Males 15-29 Age Specific Rate 140.8
2012-13 Males 15-29 Age Specific Rate 145.9
2013-14 Males 15-29 Age Specific Rate 146.9
2014-15 Males 15-29 Age Specific Rate 154.8
2015-16 Males 15-29 Age Specific Rate 164.5
2016-17 Males 15-29 Age Specific Rate 164.0
2017-18 Males 15-29 Age Specific Rate 165.4
2018-19 Males 15-29 Age Specific Rate 171.0
2019-20 Males 15-29 Age Specific Rate 165.4
2020-21 Males 15-29 Age Specific Rate 181.5
2002-03 Males 30-44 Age Specific Rate 200.1
2003-04 Males 30-44 Age Specific Rate 196.3
2004-05 Males 30-44 Age Specific Rate 195.3
2005-06 Males 30-44 Age Specific Rate 196.1
2006-07 Males 30-44 Age Specific Rate 196.8
2007-08 Males 30-44 Age Specific Rate 203.7
2008-09 Males 30-44 Age Specific Rate 205.6
2009-10 Males 30-44 Age Specific Rate 207.1
2010-11 Males 30-44 Age Specific Rate 210.5
2011-12 Males 30-44 Age Specific Rate 216.0
2012-13 Males 30-44 Age Specific Rate 224.3
2013-14 Males 30-44 Age Specific Rate 229.5
2014-15 Males 30-44 Age Specific Rate 240.2
2015-16 Males 30-44 Age Specific Rate 245.2
2016-17 Males 30-44 Age Specific Rate 254.0
2017-18 Males 30-44 Age Specific Rate 259.7
2018-19 Males 30-44 Age Specific Rate 264.4
2019-20 Males 30-44 Age Specific Rate 258.2
2020-21 Males 30-44 Age Specific Rate 277.9
2002-03 Males 45-64 Age Specific Rate 424.1
2003-04 Males 45-64 Age Specific Rate 428.4
2004-05 Males 45-64 Age Specific Rate 431.9
2005-06 Males 45-64 Age Specific Rate 438.1
2006-07 Males 45-64 Age Specific Rate 450.7
2007-08 Males 45-64 Age Specific Rate 469.8
2008-09 Males 45-64 Age Specific Rate 476.8
2009-10 Males 45-64 Age Specific Rate 485.7
2010-11 Males 45-64 Age Specific Rate 491.0
2011-12 Males 45-64 Age Specific Rate 493.2
2012-13 Males 45-64 Age Specific Rate 490.7
2013-14 Males 45-64 Age Specific Rate 500.0
2014-15 Males 45-64 Age Specific Rate 532.8
2015-16 Males 45-64 Age Specific Rate 547.1
2016-17 Males 45-64 Age Specific Rate 565.3
2017-18 Males 45-64 Age Specific Rate 587.4
2018-19 Males 45-64 Age Specific Rate 597.7
2019-20 Males 45-64 Age Specific Rate 589.8
2020-21 Males 45-64 Age Specific Rate 619.7
2002-03 Males 65+ Age Specific Rate 1,057.8
2003-04 Males 65+ Age Specific Rate 1,101.5
2004-05 Males 65+ Age Specific Rate 1,141.3
2005-06 Males 65+ Age Specific Rate 1,160.4
2006-07 Males 65+ Age Specific Rate 1,182.9
2007-08 Males 65+ Age Specific Rate 1,215.3
2008-09 Males 65+ Age Specific Rate 1,242.3
2009-10 Males 65+ Age Specific Rate 1,265.8
2010-11 Males 65+ Age Specific Rate 1,299.6
2011-12 Males 65+ Age Specific Rate 1,327.1
2012-13 Males 65+ Age Specific Rate 1,332.0
2013-14 Males 65+ Age Specific Rate 1,349.4
2014-15 Males 65+ Age Specific Rate 1,434.8
2015-16 Males 65+ Age Specific Rate 1,483.1
2016-17 Males 65+ Age Specific Rate 1,522.4
2017-18 Males 65+ Age Specific Rate 1,555.5
2018-19 Males 65+ Age Specific Rate 1,586.5
2019-20 Males 65+ Age Specific Rate 1,548.3
2020-21 Males 65+ Age Specific Rate 1,586.9
2002-03 Females 0-14 Age Specific Rate 113.5
2003-04 Females 0-14 Age Specific Rate 114.4
2004-05 Females 0-14 Age Specific Rate 110.7
2005-06 Females 0-14 Age Specific Rate 112.2
2006-07 Females 0-14 Age Specific Rate 111.9
2007-08 Females 0-14 Age Specific Rate 115.0
2008-09 Females 0-14 Age Specific Rate 120.1
2009-10 Females 0-14 Age Specific Rate 117.6
2010-11 Females 0-14 Age Specific Rate 116.3
2011-12 Females 0-14 Age Specific Rate 118.0
2012-13 Females 0-14 Age Specific Rate 120.7
2013-14 Females 0-14 Age Specific Rate 126.0
2014-15 Females 0-14 Age Specific Rate 130.3
2015-16 Females 0-14 Age Specific Rate 135.7
2016-17 Females 0-14 Age Specific Rate 136.9
2017-18 Females 0-14 Age Specific Rate 142.0
2018-19 Females 0-14 Age Specific Rate 140.7
2019-20 Females 0-14 Age Specific Rate 132.4
2020-21 Females 0-14 Age Specific Rate 141.5
2002-03 Females 15-29 Age Specific Rate 289.7
2003-04 Females 15-29 Age Specific Rate 289.1
2004-05 Females 15-29 Age Specific Rate 292.9
2005-06 Females 15-29 Age Specific Rate 298.1
2006-07 Females 15-29 Age Specific Rate 301.5
2007-08 Females 15-29 Age Specific Rate 303.7
2008-09 Females 15-29 Age Specific Rate 302.5
2009-10 Females 15-29 Age Specific Rate 297.0
2010-11 Females 15-29 Age Specific Rate 291.9
2011-12 Females 15-29 Age Specific Rate 304.9
2012-13 Females 15-29 Age Specific Rate 317.2
2013-14 Females 15-29 Age Specific Rate 320.4
2014-15 Females 15-29 Age Specific Rate 329.5
2015-16 Females 15-29 Age Specific Rate 341.5
2016-17 Females 15-29 Age Specific Rate 358.0
2017-18 Females 15-29 Age Specific Rate 373.3
2018-19 Females 15-29 Age Specific Rate 391.1
2019-20 Females 15-29 Age Specific Rate 384.7
2020-21 Females 15-29 Age Specific Rate 424.0
2002-03 Females 30-44 Age Specific Rate 333.1
2003-04 Females 30-44 Age Specific Rate 337.4
2004-05 Females 30-44 Age Specific Rate 347.3
2005-06 Females 30-44 Age Specific Rate 351.9
2006-07 Females 30-44 Age Specific Rate 359.3
2007-08 Females 30-44 Age Specific Rate 364.1
2008-09 Females 30-44 Age Specific Rate 374.2
2009-10 Females 30-44 Age Specific Rate 380.7
2010-11 Females 30-44 Age Specific Rate 376.2
2011-12 Females 30-44 Age Specific Rate 383.7
2012-13 Females 30-44 Age Specific Rate 396.0
2013-14 Females 30-44 Age Specific Rate 407.5
2014-15 Females 30-44 Age Specific Rate 421.2
2015-16 Females 30-44 Age Specific Rate 445.1
2016-17 Females 30-44 Age Specific Rate 463.5
2017-18 Females 30-44 Age Specific Rate 476.8
2018-19 Females 30-44 Age Specific Rate 496.7
2019-20 Females 30-44 Age Specific Rate 492.8
2020-21 Females 30-44 Age Specific Rate 537.4
2002-03 Females 45-64 Age Specific Rate 426.4
2003-04 Females 45-64 Age Specific Rate 424.5
2004-05 Females 45-64 Age Specific Rate 422.0
2005-06 Females 45-64 Age Specific Rate 424.2
2006-07 Females 45-64 Age Specific Rate 432.8
2007-08 Females 45-64 Age Specific Rate 445.9
2008-09 Females 45-64 Age Specific Rate 460.8
2009-10 Females 45-64 Age Specific Rate 468.5
2010-11 Females 45-64 Age Specific Rate 474.0
2011-12 Females 45-64 Age Specific Rate 476.6
2012-13 Females 45-64 Age Specific Rate 478.6
2013-14 Females 45-64 Age Specific Rate 501.2
2014-15 Females 45-64 Age Specific Rate 533.4
2015-16 Females 45-64 Age Specific Rate 552.3
2016-17 Females 45-64 Age Specific Rate 571.6
2017-18 Females 45-64 Age Specific Rate 589.7
2018-19 Females 45-64 Age Specific Rate 597.3
2019-20 Females 45-64 Age Specific Rate 588.3
2020-21 Females 45-64 Age Specific Rate 622.0
2002-03 Females 65+ Age Specific Rate 852.3
2003-04 Females 65+ Age Specific Rate 886.7
2004-05 Females 65+ Age Specific Rate 904.2
2005-06 Females 65+ Age Specific Rate 908.7
2006-07 Females 65+ Age Specific Rate 927.7
2007-08 Females 65+ Age Specific Rate 950.1
2008-09 Females 65+ Age Specific Rate 994.0
2009-10 Females 65+ Age Specific Rate 1,027.6
2010-11 Females 65+ Age Specific Rate 1,043.7
2011-12 Females 65+ Age Specific Rate 1,068.5
2012-13 Females 65+ Age Specific Rate 1,070.0
2013-14 Females 65+ Age Specific Rate 1,078.2
2014-15 Females 65+ Age Specific Rate 1,159.3
2015-16 Females 65+ Age Specific Rate 1,190.4
2016-17 Females 65+ Age Specific Rate 1,229.7
2017-18 Females 65+ Age Specific Rate 1,246.7
2018-19 Females 65+ Age Specific Rate 1,246.7
2019-20 Females 65+ Age Specific Rate 1,204.3
2020-21 Females 65+ Age Specific Rate 1,246.5
2002-03 Persons Total Age Standardised Rate 350.1
2003-04 Persons Total Age Standardised Rate 355.2
2004-05 Persons Total Age Standardised Rate 358.7
2005-06 Persons Total Age Standardised Rate 361.8
2006-07 Persons Total Age Standardised Rate 368.2
2007-08 Persons Total Age Standardised Rate 377.5
2008-09 Persons Total Age Standardised Rate 386.7
2009-10 Persons Total Age Standardised Rate 391.6
2010-11 Persons Total Age Standardised Rate 394.4
2011-12 Persons Total Age Standardised Rate 402.3
2012-13 Persons Total Age Standardised Rate 408.1
2013-14 Persons Total Age Standardised Rate 417.3
2014-15 Persons Total Age Standardised Rate 440.8
2015-16 Persons Total Age Standardised Rate 456.8
2016-17 Persons Total Age Standardised Rate 471.7
2017-18 Persons Total Age Standardised Rate 483.5
2018-19 Persons Total Age Standardised Rate 492.6
2019-20 Persons Total Age Standardised Rate 480.7
2020-21 Persons Total Age Standardised Rate 507.4
2002-03 Males Total Age Standardised Rate 339.2
2003-04 Males Total Age Standardised Rate 345.1
2004-05 Males Total Age Standardised Rate 348.3
2005-06 Males Total Age Standardised Rate 351.7
2006-07 Males Total Age Standardised Rate 357.8
2007-08 Males Total Age Standardised Rate 368.9
2008-09 Males Total Age Standardised Rate 375.5
2009-10 Males Total Age Standardised Rate 379.7
2010-11 Males Total Age Standardised Rate 384.3
2011-12 Males Total Age Standardised Rate 391.2
2012-13 Males Total Age Standardised Rate 395.9
2013-14 Males Total Age Standardised Rate 403.2
2014-15 Males Total Age Standardised Rate 426.5
2015-16 Males Total Age Standardised Rate 441.1
2016-17 Males Total Age Standardised Rate 452.8
2017-18 Males Total Age Standardised Rate 463.2
2018-19 Males Total Age Standardised Rate 471.6
2019-20 Males Total Age Standardised Rate 459.0
2020-21 Males Total Age Standardised Rate 479.5
2002-03 Females Total Age Standardised Rate 364.9
2003-04 Females Total Age Standardised Rate 369.5
2004-05 Females Total Age Standardised Rate 373.4
2005-06 Females Total Age Standardised Rate 376.8
2006-07 Females Total Age Standardised Rate 383.3
2007-08 Females Total Age Standardised Rate 390.7
2008-09 Females Total Age Standardised Rate 402.3
2009-10 Females Total Age Standardised Rate 407.8
2010-11 Females Total Age Standardised Rate 408.7
2011-12 Females Total Age Standardised Rate 417.5
2012-13 Females Total Age Standardised Rate 424.2
2013-14 Females Total Age Standardised Rate 435.0
2014-15 Females Total Age Standardised Rate 458.4
2015-16 Females Total Age Standardised Rate 475.6
2016-17 Females Total Age Standardised Rate 493.2
2017-18 Females Total Age Standardised Rate 506.2
2018-19 Females Total Age Standardised Rate 515.9
2019-20 Females Total Age Standardised Rate 504.5
2020-21 Females Total Age Standardised Rate 537.1

Broad causes of hospitalisations

Admitted patient episodes of care are coded using the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM).2 ICD codes divide diseases and health conditions into similar categories (ICD chapters) based on the type of disease, the body systems affected, or the circumstances that caused the condition. While changes to ICD coding over time affect the interpretability of the results, understanding admission patterns by ICD chapters provides insights into the broad reasons why people are hospitalised.

Based on principal diagnosis, standardised rates for:

  • Factors influencing health status and contact with health services, which includes admissions for routine therapy such as dialysis and chemotherapy, are the most common type for males and females (Figure 2). Repeated hospital admissions for routine therapy are often required for chronic conditions which, in part, contributes to increasing admission rates.
  • People 65 years and older have the highest age-specific rate for these types of admissions and most admissions included in other ICD chapters. Exceptions include those related to childbirth, congenital abnormalities and mental health conditions.

Figure 2: Queensland hospital admission rates by ICD chapter, 2020–21

Figure 2a: Queensland hospital admission rates by ICD chapter, 2020–21 (persons)
Bar graph showing the age standardised rates by broad ICD-10-AM chapters for2020-21 for persons
Figure 2b: Queensland hospital admission rates by ICD chapter, 2020–21 (males)
Bar graph showing the age standardised rates by broad ICD-10-AM chapters for2020-21 for males
Figure 2c: Queensland hospital admission rates by ICD chapter, 2020–21 (females)
Bar graph showing the age standardised rates by broad ICD-10-AM chapters for 2020-21 for females
Figure 2d: Queensland hospital admission rates by ICD chapter, 2020–21 (table) Ordered by condition
SexCondition Age GroupType Rates (per 1,000 persons)
Persons A00 - B99 Infectious and parasitic diseases 0-14 Age Specific Rate 7.7
Persons A00 - B99 Infectious and parasitic diseases 15-29 Age Specific Rate 4.7
Persons A00 - B99 Infectious and parasitic diseases 30-44 Age Specific Rate 5.0
Persons A00 - B99 Infectious and parasitic diseases 45-64 Age Specific Rate 7.0
Persons A00 - B99 Infectious and parasitic diseases 65+ Age Specific Rate 18.8
Males A00 - B99 Infectious and parasitic diseases 0-14 Age Specific Rate 8.0
Males A00 - B99 Infectious and parasitic diseases 15-29 Age Specific Rate 3.7
Males A00 - B99 Infectious and parasitic diseases 30-44 Age Specific Rate 4.3
Males A00 - B99 Infectious and parasitic diseases 45-64 Age Specific Rate 6.7
Males A00 - B99 Infectious and parasitic diseases 65+ Age Specific Rate 19.6
Females A00 - B99 Infectious and parasitic diseases 0-14 Age Specific Rate 7.4
Females A00 - B99 Infectious and parasitic diseases 15-29 Age Specific Rate 5.7
Females A00 - B99 Infectious and parasitic diseases 30-44 Age Specific Rate 5.6
Females A00 - B99 Infectious and parasitic diseases 45-64 Age Specific Rate 7.3
Females A00 - B99 Infectious and parasitic diseases 65+ Age Specific Rate 18.1
Persons A00 - B99 Infectious and parasitic diseases Total Age Standardised Rate 7.7
Males A00 - B99 Infectious and parasitic diseases Total Age Standardised Rate 7.5
Females A00 - B99 Infectious and parasitic diseases Total Age Standardised Rate 7.9
Persons A00 - B99 Infectious and parasitic diseases Total Crude Rate 8.2
Males A00 - B99 Infectious and parasitic diseases Total Crude Rate 7.9
Females A00 - B99 Infectious and parasitic diseases Total Crude Rate 8.4
Persons C00 - C97 Malignant neoplasms 0-14 Age Specific Rate 1.4
Persons C00 - C97 Malignant neoplasms 15-29 Age Specific Rate 1.2
Persons C00 - C97 Malignant neoplasms 30-44 Age Specific Rate 5.0
Persons C00 - C97 Malignant neoplasms 45-64 Age Specific Rate 24.7
Persons C00 - C97 Malignant neoplasms 65+ Age Specific Rate 81.5
Males C00 - C97 Malignant neoplasms 0-14 Age Specific Rate 1.5
Males C00 - C97 Malignant neoplasms 15-29 Age Specific Rate 1.3
Males C00 - C97 Malignant neoplasms 30-44 Age Specific Rate 4.2
Males C00 - C97 Malignant neoplasms 45-64 Age Specific Rate 27.1
Males C00 - C97 Malignant neoplasms 65+ Age Specific Rate 105.5
Females C00 - C97 Malignant neoplasms 0-14 Age Specific Rate 1.3
Females C00 - C97 Malignant neoplasms 15-29 Age Specific Rate 1.1
Females C00 - C97 Malignant neoplasms 30-44 Age Specific Rate 5.8
Females C00 - C97 Malignant neoplasms 45-64 Age Specific Rate 22.5
Females C00 - C97 Malignant neoplasms 65+ Age Specific Rate 59.7
Persons C00 - C97 Malignant neoplasms Total Age Standardised Rate 17.4
Males C00 - C97 Malignant neoplasms Total Age Standardised Rate 20.9
Females C00 - C97 Malignant neoplasms Total Age Standardised Rate 14.3
Persons C00 - C97 Malignant neoplasms Total Crude Rate 20.7
Males C00 - C97 Malignant neoplasms Total Crude Rate 24.3
Females C00 - C97 Malignant neoplasms Total Crude Rate 17.2
Persons D00 - D48 Benign and other neoplasms 0-14 Age Specific Rate 1.2
Persons D00 - D48 Benign and other neoplasms 15-29 Age Specific Rate 2.7
Persons D00 - D48 Benign and other neoplasms 30-44 Age Specific Rate 8.9
Persons D00 - D48 Benign and other neoplasms 45-64 Age Specific Rate 20.0
Persons D00 - D48 Benign and other neoplasms 65+ Age Specific Rate 45.0
Males D00 - D48 Benign and other neoplasms 0-14 Age Specific Rate 1.2
Males D00 - D48 Benign and other neoplasms 15-29 Age Specific Rate 1.1
Males D00 - D48 Benign and other neoplasms 30-44 Age Specific Rate 5.0
Males D00 - D48 Benign and other neoplasms 45-64 Age Specific Rate 19.2
Males D00 - D48 Benign and other neoplasms 65+ Age Specific Rate 54.3
Females D00 - D48 Benign and other neoplasms 0-14 Age Specific Rate 1.3
Females D00 - D48 Benign and other neoplasms 15-29 Age Specific Rate 4.3
Females D00 - D48 Benign and other neoplasms 30-44 Age Specific Rate 12.6
Females D00 - D48 Benign and other neoplasms 45-64 Age Specific Rate 20.7
Females D00 - D48 Benign and other neoplasms 65+ Age Specific Rate 36.6
Persons D00 - D48 Benign and other neoplasms Total Age Standardised Rate 13.0
Males D00 - D48 Benign and other neoplasms Total Age Standardised Rate 12.7
Females D00 - D48 Benign and other neoplasms Total Age Standardised Rate 13.4
Persons D00 - D48 Benign and other neoplasms Total Crude Rate 14.7
Males D00 - D48 Benign and other neoplasms Total Crude Rate 14.5
Females D00 - D48 Benign and other neoplasms Total Crude Rate 14.9
Persons D50 - D89 Diseases of blood and blood forming organs etc 0-14 Age Specific Rate 1.6
Persons D50 - D89 Diseases of blood and blood forming organs etc 15-29 Age Specific Rate 3.2
Persons D50 - D89 Diseases of blood and blood forming organs etc 30-44 Age Specific Rate 5.4
Persons D50 - D89 Diseases of blood and blood forming organs etc 45-64 Age Specific Rate 11.1
Persons D50 - D89 Diseases of blood and blood forming organs etc 65+ Age Specific Rate 37.8
Males D50 - D89 Diseases of blood and blood forming organs etc 0-14 Age Specific Rate 1.6
Males D50 - D89 Diseases of blood and blood forming organs etc 15-29 Age Specific Rate 2.4
Males D50 - D89 Diseases of blood and blood forming organs etc 30-44 Age Specific Rate 3.3
Males D50 - D89 Diseases of blood and blood forming organs etc 45-64 Age Specific Rate 9.6
Males D50 - D89 Diseases of blood and blood forming organs etc 65+ Age Specific Rate 40.1
Females D50 - D89 Diseases of blood and blood forming organs etc 0-14 Age Specific Rate 1.6
Females D50 - D89 Diseases of blood and blood forming organs etc 15-29 Age Specific Rate 4.0
Females D50 - D89 Diseases of blood and blood forming organs etc 30-44 Age Specific Rate 7.4
Females D50 - D89 Diseases of blood and blood forming organs etc 45-64 Age Specific Rate 12.6
Females D50 - D89 Diseases of blood and blood forming organs etc 65+ Age Specific Rate 35.7
Persons D50 - D89 Diseases of blood and blood forming organs etc Total Age Standardised Rate 9.6
Males D50 - D89 Diseases of blood and blood forming organs etc Total Age Standardised Rate 8.9
Females D50 - D89 Diseases of blood and blood forming organs etc Total Age Standardised Rate 10.2
Persons D50 - D89 Diseases of blood and blood forming organs etc Total Crude Rate 10.8
Males D50 - D89 Diseases of blood and blood forming organs etc Total Crude Rate 10.0
Females D50 - D89 Diseases of blood and blood forming organs etc Total Crude Rate 11.7
Persons E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes 0-14 Age Specific Rate 2.7
Persons E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes 15-29 Age Specific Rate 5.5
Persons E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes 30-44 Age Specific Rate 9.5
Persons E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes 45-64 Age Specific Rate 13.7
Persons E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes 65+ Age Specific Rate 21.6
Males E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes 0-14 Age Specific Rate 2.7
Males E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes 15-29 Age Specific Rate 2.7
Males E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes 30-44 Age Specific Rate 5.1
Males E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes 45-64 Age Specific Rate 11.2
Males E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes 65+ Age Specific Rate 23.6
Females E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes 0-14 Age Specific Rate 2.7
Females E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes 15-29 Age Specific Rate 8.3
Females E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes 30-44 Age Specific Rate 13.8
Females E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes 45-64 Age Specific Rate 16.0
Females E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes 65+ Age Specific Rate 19.9
Persons E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Total Age Standardised Rate 9.8
Males E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Total Age Standardised Rate 7.9
Females E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Total Age Standardised Rate 11.7
Persons E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Total Crude Rate 10.4
Males E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Total Crude Rate 8.5
Females E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Total Crude Rate 12.2
Persons F00 - F99 Mental and behavioural disorders 0-14 Age Specific Rate 1.9
Persons F00 - F99 Mental and behavioural disorders 15-29 Age Specific Rate 28.4
Persons F00 - F99 Mental and behavioural disorders 30-44 Age Specific Rate 36.0
Persons F00 - F99 Mental and behavioural disorders 45-64 Age Specific Rate 35.1
Persons F00 - F99 Mental and behavioural disorders 65+ Age Specific Rate 33.5
Males F00 - F99 Mental and behavioural disorders 0-14 Age Specific Rate 1.3
Males F00 - F99 Mental and behavioural disorders 15-29 Age Specific Rate 18.8
Males F00 - F99 Mental and behavioural disorders 30-44 Age Specific Rate 31.6
Males F00 - F99 Mental and behavioural disorders 45-64 Age Specific Rate 30.1
Males F00 - F99 Mental and behavioural disorders 65+ Age Specific Rate 31.0
Females F00 - F99 Mental and behavioural disorders 0-14 Age Specific Rate 2.5
Females F00 - F99 Mental and behavioural disorders 15-29 Age Specific Rate 38.2
Females F00 - F99 Mental and behavioural disorders 30-44 Age Specific Rate 40.2
Females F00 - F99 Mental and behavioural disorders 45-64 Age Specific Rate 39.9
Females F00 - F99 Mental and behavioural disorders 65+ Age Specific Rate 35.7
Persons F00 - F99 Mental and behavioural disorders Total Age Standardised Rate 27.0
Males F00 - F99 Mental and behavioural disorders Total Age Standardised Rate 22.5
Females F00 - F99 Mental and behavioural disorders Total Age Standardised Rate 31.5
Persons F00 - F99 Mental and behavioural disorders Total Crude Rate 27.3
Males F00 - F99 Mental and behavioural disorders Total Crude Rate 22.5
Females F00 - F99 Mental and behavioural disorders Total Crude Rate 32.0
Persons G00 - G99 Nervous system and sense organ disorders 0-14 Age Specific Rate 6.1
Persons G00 - G99 Nervous system and sense organ disorders 15-29 Age Specific Rate 7.0
Persons G00 - G99 Nervous system and sense organ disorders 30-44 Age Specific Rate 12.3
Persons G00 - G99 Nervous system and sense organ disorders 45-64 Age Specific Rate 22.0
Persons G00 - G99 Nervous system and sense organ disorders 65+ Age Specific Rate 38.4
Males G00 - G99 Nervous system and sense organ disorders 0-14 Age Specific Rate 6.4
Males G00 - G99 Nervous system and sense organ disorders 15-29 Age Specific Rate 5.4
Males G00 - G99 Nervous system and sense organ disorders 30-44 Age Specific Rate 9.8
Males G00 - G99 Nervous system and sense organ disorders 45-64 Age Specific Rate 20.8
Males G00 - G99 Nervous system and sense organ disorders 65+ Age Specific Rate 46.2
Females G00 - G99 Nervous system and sense organ disorders 0-14 Age Specific Rate 5.7
Females G00 - G99 Nervous system and sense organ disorders 15-29 Age Specific Rate 8.7
Females G00 - G99 Nervous system and sense organ disorders 30-44 Age Specific Rate 14.7
Females G00 - G99 Nervous system and sense organ disorders 45-64 Age Specific Rate 23.1
Females G00 - G99 Nervous system and sense organ disorders 65+ Age Specific Rate 31.3
Persons G00 - G99 Nervous system and sense organ disorders Total Age Standardised Rate 15.4
Males G00 - G99 Nervous system and sense organ disorders Total Age Standardised Rate 15.3
Females G00 - G99 Nervous system and sense organ disorders Total Age Standardised Rate 15.6
Persons G00 - G99 Nervous system and sense organ disorders Total Crude Rate 16.6
Males G00 - G99 Nervous system and sense organ disorders Total Crude Rate 16.5
Females G00 - G99 Nervous system and sense organ disorders Total Crude Rate 16.7
Persons H00 - H59 Diseases of eye and adnexa 0-14 Age Specific Rate 1.5
Persons H00 - H59 Diseases of eye and adnexa 15-29 Age Specific Rate 1.2
Persons H00 - H59 Diseases of eye and adnexa 30-44 Age Specific Rate 2.7
Persons H00 - H59 Diseases of eye and adnexa 45-64 Age Specific Rate 18.7
Persons H00 - H59 Diseases of eye and adnexa 65+ Age Specific Rate 103.9
Males H00 - H59 Diseases of eye and adnexa 0-14 Age Specific Rate 1.5
Males H00 - H59 Diseases of eye and adnexa 15-29 Age Specific Rate 1.2
Males H00 - H59 Diseases of eye and adnexa 30-44 Age Specific Rate 2.7
Males H00 - H59 Diseases of eye and adnexa 45-64 Age Specific Rate 18.4
Males H00 - H59 Diseases of eye and adnexa 65+ Age Specific Rate 101.4
Females H00 - H59 Diseases of eye and adnexa 0-14 Age Specific Rate 1.4
Females H00 - H59 Diseases of eye and adnexa 15-29 Age Specific Rate 1.3
Females H00 - H59 Diseases of eye and adnexa 30-44 Age Specific Rate 2.7
Females H00 - H59 Diseases of eye and adnexa 45-64 Age Specific Rate 18.9
Females H00 - H59 Diseases of eye and adnexa 65+ Age Specific Rate 106.1
Persons H00 - H59 Diseases of eye and adnexa Total Age Standardised Rate 18.5
Males H00 - H59 Diseases of eye and adnexa Total Age Standardised Rate 18.3
Females H00 - H59 Diseases of eye and adnexa Total Age Standardised Rate 18.7
Persons H00 - H59 Diseases of eye and adnexa Total Crude Rate 22.4
Males H00 - H59 Diseases of eye and adnexa Total Crude Rate 21.2
Females H00 - H59 Diseases of eye and adnexa Total Crude Rate 23.5
Persons H60 - H95 Diseases of ear and mastoid process 0-14 Age Specific Rate 4.5
Persons H60 - H95 Diseases of ear and mastoid process 15-29 Age Specific Rate 1.4
Persons H60 - H95 Diseases of ear and mastoid process 30-44 Age Specific Rate 2.2
Persons H60 - H95 Diseases of ear and mastoid process 45-64 Age Specific Rate 3.6
Persons H60 - H95 Diseases of ear and mastoid process 65+ Age Specific Rate 6.3
Males H60 - H95 Diseases of ear and mastoid process 0-14 Age Specific Rate 5.4
Males H60 - H95 Diseases of ear and mastoid process 15-29 Age Specific Rate 1.3
Males H60 - H95 Diseases of ear and mastoid process 30-44 Age Specific Rate 1.9
Males H60 - H95 Diseases of ear and mastoid process 45-64 Age Specific Rate 3.3
Males H60 - H95 Diseases of ear and mastoid process 65+ Age Specific Rate 6.1
Females H60 - H95 Diseases of ear and mastoid process 0-14 Age Specific Rate 3.6
Females H60 - H95 Diseases of ear and mastoid process 15-29 Age Specific Rate 1.4
Females H60 - H95 Diseases of ear and mastoid process 30-44 Age Specific Rate 2.4
Females H60 - H95 Diseases of ear and mastoid process 45-64 Age Specific Rate 3.8
Females H60 - H95 Diseases of ear and mastoid process 65+ Age Specific Rate 6.5
Persons H60 - H95 Diseases of ear and mastoid process Total Age Standardised Rate 3.3
Males H60 - H95 Diseases of ear and mastoid process Total Age Standardised Rate 3.4
Females H60 - H95 Diseases of ear and mastoid process Total Age Standardised Rate 3.3
Persons H60 - H95 Diseases of ear and mastoid process Total Crude Rate 3.5
Males H60 - H95 Diseases of ear and mastoid process Total Crude Rate 3.5
Females H60 - H95 Diseases of ear and mastoid process Total Crude Rate 3.5
Persons I00 - I99 Diseases of circulatory system 0-14 Age Specific Rate 1.6
Persons I00 - I99 Diseases of circulatory system 15-29 Age Specific Rate 2.8
Persons I00 - I99 Diseases of circulatory system 30-44 Age Specific Rate 6.9
Persons I00 - I99 Diseases of circulatory system 45-64 Age Specific Rate 27.8
Persons I00 - I99 Diseases of circulatory system 65+ Age Specific Rate 109.1
Males I00 - I99 Diseases of circulatory system 0-14 Age Specific Rate 1.6
Males I00 - I99 Diseases of circulatory system 15-29 Age Specific Rate 3.0
Males I00 - I99 Diseases of circulatory system 30-44 Age Specific Rate 7.4
Males I00 - I99 Diseases of circulatory system 45-64 Age Specific Rate 36.2
Males I00 - I99 Diseases of circulatory system 65+ Age Specific Rate 130.0
Females I00 - I99 Diseases of circulatory system 0-14 Age Specific Rate 1.5
Females I00 - I99 Diseases of circulatory system 15-29 Age Specific Rate 2.6
Females I00 - I99 Diseases of circulatory system 30-44 Age Specific Rate 6.3
Females I00 - I99 Diseases of circulatory system 45-64 Age Specific Rate 19.9
Females I00 - I99 Diseases of circulatory system 65+ Age Specific Rate 90.2
Persons I00 - I99 Diseases of circulatory system Total Age Standardised Rate 22.6
Males I00 - I99 Diseases of circulatory system Total Age Standardised Rate 27.6
Females I00 - I99 Diseases of circulatory system Total Age Standardised Rate 18.0
Persons I00 - I99 Diseases of circulatory system Total Crude Rate 26.6
Males I00 - I99 Diseases of circulatory system Total Crude Rate 31.3
Females I00 - I99 Diseases of circulatory system Total Crude Rate 22.1
Persons J00 - J99 Diseases of respiratory system 0-14 Age Specific Rate 26.3
Persons J00 - J99 Diseases of respiratory system 15-29 Age Specific Rate 9.5
Persons J00 - J99 Diseases of respiratory system 30-44 Age Specific Rate 9.0
Persons J00 - J99 Diseases of respiratory system 45-64 Age Specific Rate 13.8
Persons J00 - J99 Diseases of respiratory system 65+ Age Specific Rate 42.3
Males J00 - J99 Diseases of respiratory system 0-14 Age Specific Rate 30.3
Males J00 - J99 Diseases of respiratory system 15-29 Age Specific Rate 7.8
Males J00 - J99 Diseases of respiratory system 30-44 Age Specific Rate 9.0
Males J00 - J99 Diseases of respiratory system 45-64 Age Specific Rate 13.6
Males J00 - J99 Diseases of respiratory system 65+ Age Specific Rate 46.8
Females J00 - J99 Diseases of respiratory system 0-14 Age Specific Rate 22.1
Females J00 - J99 Diseases of respiratory system 15-29 Age Specific Rate 11.3
Females J00 - J99 Diseases of respiratory system 30-44 Age Specific Rate 9.0
Females J00 - J99 Diseases of respiratory system 45-64 Age Specific Rate 14.0
Females J00 - J99 Diseases of respiratory system 65+ Age Specific Rate 38.2
Persons J00 - J99 Diseases of respiratory system Total Age Standardised Rate 18.0
Males J00 - J99 Diseases of respiratory system Total Age Standardised Rate 19.2
Females J00 - J99 Diseases of respiratory system Total Age Standardised Rate 17.0
Persons J00 - J99 Diseases of respiratory system Total Crude Rate 19.0
Males J00 - J99 Diseases of respiratory system Total Crude Rate 20.0
Females J00 - J99 Diseases of respiratory system Total Crude Rate 18.0
Persons K00 - K93 Diseases of the digestive system 0-14 Age Specific Rate 14.9
Persons K00 - K93 Diseases of the digestive system 15-29 Age Specific Rate 36.6
Persons K00 - K93 Diseases of the digestive system 30-44 Age Specific Rate 45.0
Persons K00 - K93 Diseases of the digestive system 45-64 Age Specific Rate 67.7
Persons K00 - K93 Diseases of the digestive system 65+ Age Specific Rate 99.0
Males K00 - K93 Diseases of the digestive system 0-14 Age Specific Rate 15.7
Males K00 - K93 Diseases of the digestive system 15-29 Age Specific Rate 30.4
Males K00 - K93 Diseases of the digestive system 30-44 Age Specific Rate 43.9
Males K00 - K93 Diseases of the digestive system 45-64 Age Specific Rate 68.8
Males K00 - K93 Diseases of the digestive system 65+ Age Specific Rate 105.4
Females K00 - K93 Diseases of the digestive system 0-14 Age Specific Rate 14.2
Females K00 - K93 Diseases of the digestive system 15-29 Age Specific Rate 42.9
Females K00 - K93 Diseases of the digestive system 30-44 Age Specific Rate 46.1
Females K00 - K93 Diseases of the digestive system 45-64 Age Specific Rate 66.7
Females K00 - K93 Diseases of the digestive system 65+ Age Specific Rate 93.2
Persons K00 - K93 Diseases of the digestive system Total Age Standardised Rate 49.0
Males K00 - K93 Diseases of the digestive system Total Age Standardised Rate 48.6
Females K00 - K93 Diseases of the digestive system Total Age Standardised Rate 49.4
Persons K00 - K93 Diseases of the digestive system Total Crude Rate 51.8
Males K00 - K93 Diseases of the digestive system Total Crude Rate 51.1
Females K00 - K93 Diseases of the digestive system Total Crude Rate 52.5
Persons L00 - L99 Diseases of skin and subcutaneous tissue 0-14 Age Specific Rate 4.0
Persons L00 - L99 Diseases of skin and subcutaneous tissue 15-29 Age Specific Rate 6.5
Persons L00 - L99 Diseases of skin and subcutaneous tissue 30-44 Age Specific Rate 7.5
Persons L00 - L99 Diseases of skin and subcutaneous tissue 45-64 Age Specific Rate 9.6
Persons L00 - L99 Diseases of skin and subcutaneous tissue 65+ Age Specific Rate 18.1
Males L00 - L99 Diseases of skin and subcutaneous tissue 0-14 Age Specific Rate 4.1
Males L00 - L99 Diseases of skin and subcutaneous tissue 15-29 Age Specific Rate 7.2
Males L00 - L99 Diseases of skin and subcutaneous tissue 30-44 Age Specific Rate 8.2
Males L00 - L99 Diseases of skin and subcutaneous tissue 45-64 Age Specific Rate 9.9
Males L00 - L99 Diseases of skin and subcutaneous tissue 65+ Age Specific Rate 19.9
Females L00 - L99 Diseases of skin and subcutaneous tissue 0-14 Age Specific Rate 3.8
Females L00 - L99 Diseases of skin and subcutaneous tissue 15-29 Age Specific Rate 5.8
Females L00 - L99 Diseases of skin and subcutaneous tissue 30-44 Age Specific Rate 6.8
Females L00 - L99 Diseases of skin and subcutaneous tissue 45-64 Age Specific Rate 9.3
Females L00 - L99 Diseases of skin and subcutaneous tissue 65+ Age Specific Rate 16.4
Persons L00 - L99 Diseases of skin and subcutaneous tissue Total Age Standardised Rate 8.4
Males L00 - L99 Diseases of skin and subcutaneous tissue Total Age Standardised Rate 9.1
Females L00 - L99 Diseases of skin and subcutaneous tissue Total Age Standardised Rate 7.7
Persons L00 - L99 Diseases of skin and subcutaneous tissue Total Crude Rate 8.8
Males L00 - L99 Diseases of skin and subcutaneous tissue Total Crude Rate 9.4
Females L00 - L99 Diseases of skin and subcutaneous tissue Total Crude Rate 8.3
Persons M00 - M99 Diseases of musculoskeletal system and connective tissue 0-14 Age Specific Rate 3.3
Persons M00 - M99 Diseases of musculoskeletal system and connective tissue 15-29 Age Specific Rate 10.7
Persons M00 - M99 Diseases of musculoskeletal system and connective tissue 30-44 Age Specific Rate 19.7
Persons M00 - M99 Diseases of musculoskeletal system and connective tissue 45-64 Age Specific Rate 44.1
Persons M00 - M99 Diseases of musculoskeletal system and connective tissue 65+ Age Specific Rate 96.1
Males M00 - M99 Diseases of musculoskeletal system and connective tissue 0-14 Age Specific Rate 3.4
Males M00 - M99 Diseases of musculoskeletal system and connective tissue 15-29 Age Specific Rate 11.9
Males M00 - M99 Diseases of musculoskeletal system and connective tissue 30-44 Age Specific Rate 22.4
Males M00 - M99 Diseases of musculoskeletal system and connective tissue 45-64 Age Specific Rate 44.7
Males M00 - M99 Diseases of musculoskeletal system and connective tissue 65+ Age Specific Rate 89.9
Females M00 - M99 Diseases of musculoskeletal system and connective tissue 0-14 Age Specific Rate 3.2
Females M00 - M99 Diseases of musculoskeletal system and connective tissue 15-29 Age Specific Rate 9.5
Females M00 - M99 Diseases of musculoskeletal system and connective tissue 30-44 Age Specific Rate 17.1
Females M00 - M99 Diseases of musculoskeletal system and connective tissue 45-64 Age Specific Rate 43.4
Females M00 - M99 Diseases of musculoskeletal system and connective tissue 65+ Age Specific Rate 101.6
Persons M00 - M99 Diseases of musculoskeletal system and connective tissue Total Age Standardised Rate 29.5
Males M00 - M99 Diseases of musculoskeletal system and connective tissue Total Age Standardised Rate 29.8
Females M00 - M99 Diseases of musculoskeletal system and connective tissue Total Age Standardised Rate 29.2
Persons M00 - M99 Diseases of musculoskeletal system and connective tissue Total Crude Rate 33.0
Males M00 - M99 Diseases of musculoskeletal system and connective tissue Total Crude Rate 32.3
Females M00 - M99 Diseases of musculoskeletal system and connective tissue Total Crude Rate 33.7
Persons N00 - N99 Diseases of the genitourinary system 0-14 Age Specific Rate 4.6
Persons N00 - N99 Diseases of the genitourinary system 15-29 Age Specific Rate 17.9
Persons N00 - N99 Diseases of the genitourinary system 30-44 Age Specific Rate 27.5
Persons N00 - N99 Diseases of the genitourinary system 45-64 Age Specific Rate 29.2
Persons N00 - N99 Diseases of the genitourinary system 65+ Age Specific Rate 49.0
Males N00 - N99 Diseases of the genitourinary system 0-14 Age Specific Rate 5.3
Males N00 - N99 Diseases of the genitourinary system 15-29 Age Specific Rate 6.1
Males N00 - N99 Diseases of the genitourinary system 30-44 Age Specific Rate 9.6
Males N00 - N99 Diseases of the genitourinary system 45-64 Age Specific Rate 21.4
Males N00 - N99 Diseases of the genitourinary system 65+ Age Specific Rate 56.8
Females N00 - N99 Diseases of the genitourinary system 0-14 Age Specific Rate 3.8
Females N00 - N99 Diseases of the genitourinary system 15-29 Age Specific Rate 29.9
Females N00 - N99 Diseases of the genitourinary system 30-44 Age Specific Rate 44.6
Females N00 - N99 Diseases of the genitourinary system 45-64 Age Specific Rate 36.6
Females N00 - N99 Diseases of the genitourinary system 65+ Age Specific Rate 42.0
Persons N00 - N99 Diseases of the genitourinary system Total Age Standardised Rate 23.9
Males N00 - N99 Diseases of the genitourinary system Total Age Standardised Rate 16.7
Females N00 - N99 Diseases of the genitourinary system Total Age Standardised Rate 31.1
Persons N00 - N99 Diseases of the genitourinary system Total Crude Rate 25.0
Males N00 - N99 Diseases of the genitourinary system Total Crude Rate 18.2
Females N00 - N99 Diseases of the genitourinary system Total Crude Rate 31.7
Persons O00 - O99 Pregnancy, childbirth and puerperium 0-14 Age Specific Rate 0.0
Persons O00 - O99 Pregnancy, childbirth and puerperium 15-29 Age Specific Rate 72.6
Persons O00 - O99 Pregnancy, childbirth and puerperium 30-44 Age Specific Rate 74.2
Persons O00 - O99 Pregnancy, childbirth and puerperium 45-64 Age Specific Rate 0.3
Persons O00 - O99 Pregnancy, childbirth and puerperium 65+ Age Specific Rate 0.0
Males O00 - O99 Pregnancy, childbirth and puerperium 0-14 Age Specific Rate 0.0
Males O00 - O99 Pregnancy, childbirth and puerperium 15-29 Age Specific Rate 0.0
Males O00 - O99 Pregnancy, childbirth and puerperium 30-44 Age Specific Rate 0.0
Males O00 - O99 Pregnancy, childbirth and puerperium 45-64 Age Specific Rate 0.0
Males O00 - O99 Pregnancy, childbirth and puerperium 65+ Age Specific Rate 0.0
Females O00 - O99 Pregnancy, childbirth and puerperium 0-14 Age Specific Rate 0.1
Females O00 - O99 Pregnancy, childbirth and puerperium 15-29 Age Specific Rate 146.4
Females O00 - O99 Pregnancy, childbirth and puerperium 30-44 Age Specific Rate 145.1
Females O00 - O99 Pregnancy, childbirth and puerperium 45-64 Age Specific Rate 0.5
Females O00 - O99 Pregnancy, childbirth and puerperium 65+ Age Specific Rate 0.0
Persons O00 - O99 Pregnancy, childbirth and puerperium Total Age Standardised Rate 31.3
Males O00 - O99 Pregnancy, childbirth and puerperium Total Age Standardised Rate NA
Females O00 - O99 Pregnancy, childbirth and puerperium Total Age Standardised Rate 62.0
Persons O00 - O99 Pregnancy, childbirth and puerperium Total Crude Rate 29.4
Males O00 - O99 Pregnancy, childbirth and puerperium Total Crude Rate 0.0
Females O00 - O99 Pregnancy, childbirth and puerperium Total Crude Rate 58.2
Persons P00 - P96 Conditions originating in perinatal period 0-14 Age Specific Rate 15.9
Persons P00 - P96 Conditions originating in perinatal period 15-29 Age Specific Rate 0.0
Persons P00 - P96 Conditions originating in perinatal period 30-44 Age Specific Rate 0.0
Persons P00 - P96 Conditions originating in perinatal period 45-64 Age Specific Rate 0.0
Persons P00 - P96 Conditions originating in perinatal period 65+ Age Specific Rate 0.0
Males P00 - P96 Conditions originating in perinatal period 0-14 Age Specific Rate 17.4
Males P00 - P96 Conditions originating in perinatal period 15-29 Age Specific Rate 0.0
Males P00 - P96 Conditions originating in perinatal period 30-44 Age Specific Rate 0.0
Males P00 - P96 Conditions originating in perinatal period 45-64 Age Specific Rate 0.0
Males P00 - P96 Conditions originating in perinatal period 65+ Age Specific Rate 0.0
Females P00 - P96 Conditions originating in perinatal period 0-14 Age Specific Rate 14.4
Females P00 - P96 Conditions originating in perinatal period 15-29 Age Specific Rate 0.0
Females P00 - P96 Conditions originating in perinatal period 30-44 Age Specific Rate 0.0
Females P00 - P96 Conditions originating in perinatal period 45-64 Age Specific Rate 0.0
Females P00 - P96 Conditions originating in perinatal period 65+ Age Specific Rate 0.0
Persons P00 - P96 Conditions originating in perinatal period Total Age Standardised Rate 3.3
Males P00 - P96 Conditions originating in perinatal period Total Age Standardised Rate 3.6
Females P00 - P96 Conditions originating in perinatal period Total Age Standardised Rate 3.0
Persons P00 - P96 Conditions originating in perinatal period Total Crude Rate 3.1
Males P00 - P96 Conditions originating in perinatal period Total Crude Rate 3.5
Females P00 - P96 Conditions originating in perinatal period Total Crude Rate 2.7
Persons Q00 - Q99 Congenital anomalies 0-14 Age Specific Rate 5.3
Persons Q00 - Q99 Congenital anomalies 15-29 Age Specific Rate 1.2
Persons Q00 - Q99 Congenital anomalies 30-44 Age Specific Rate 0.8
Persons Q00 - Q99 Congenital anomalies 45-64 Age Specific Rate 0.8
Persons Q00 - Q99 Congenital anomalies 65+ Age Specific Rate 0.6
Males Q00 - Q99 Congenital anomalies 0-14 Age Specific Rate 6.7
Males Q00 - Q99 Congenital anomalies 15-29 Age Specific Rate 0.9
Males Q00 - Q99 Congenital anomalies 30-44 Age Specific Rate 0.6
Males Q00 - Q99 Congenital anomalies 45-64 Age Specific Rate 0.8
Males Q00 - Q99 Congenital anomalies 65+ Age Specific Rate 0.6
Females Q00 - Q99 Congenital anomalies 0-14 Age Specific Rate 3.8
Females Q00 - Q99 Congenital anomalies 15-29 Age Specific Rate 1.5
Females Q00 - Q99 Congenital anomalies 30-44 Age Specific Rate 1.0
Females Q00 - Q99 Congenital anomalies 45-64 Age Specific Rate 0.8
Females Q00 - Q99 Congenital anomalies 65+ Age Specific Rate 0.6
Persons Q00 - Q99 Congenital anomalies Total Age Standardised Rate 1.8
Males Q00 - Q99 Congenital anomalies Total Age Standardised Rate 2.0
Females Q00 - Q99 Congenital anomalies Total Age Standardised Rate 1.6
Persons Q00 - Q99 Congenital anomalies Total Crude Rate 1.7
Males Q00 - Q99 Congenital anomalies Total Crude Rate 1.9
Females Q00 - Q99 Congenital anomalies Total Crude Rate 1.5
Persons R00 - R99 Symptoms, signs and abnormal findings 0-14 Age Specific Rate 14.8
Persons R00 - R99 Symptoms, signs and abnormal findings 15-29 Age Specific Rate 28.0
Persons R00 - R99 Symptoms, signs and abnormal findings 30-44 Age Specific Rate 34.8
Persons R00 - R99 Symptoms, signs and abnormal findings 45-64 Age Specific Rate 59.9
Persons R00 - R99 Symptoms, signs and abnormal findings 65+ Age Specific Rate 113.2
Males R00 - R99 Symptoms, signs and abnormal findings 0-14 Age Specific Rate 14.9
Males R00 - R99 Symptoms, signs and abnormal findings 15-29 Age Specific Rate 16.4
Males R00 - R99 Symptoms, signs and abnormal findings 30-44 Age Specific Rate 27.0
Males R00 - R99 Symptoms, signs and abnormal findings 45-64 Age Specific Rate 56.5
Males R00 - R99 Symptoms, signs and abnormal findings 65+ Age Specific Rate 119.0
Females R00 - R99 Symptoms, signs and abnormal findings 0-14 Age Specific Rate 14.7
Females R00 - R99 Symptoms, signs and abnormal findings 15-29 Age Specific Rate 39.8
Females R00 - R99 Symptoms, signs and abnormal findings 30-44 Age Specific Rate 42.2
Females R00 - R99 Symptoms, signs and abnormal findings 45-64 Age Specific Rate 63.1
Females R00 - R99 Symptoms, signs and abnormal findings 65+ Age Specific Rate 108.1
Persons R00 - R99 Symptoms, signs and abnormal findings Total Age Standardised Rate 44.9
Males R00 - R99 Symptoms, signs and abnormal findings Total Age Standardised Rate 40.8
Females R00 - R99 Symptoms, signs and abnormal findings Total Age Standardised Rate 49.0
Persons R00 - R99 Symptoms, signs and abnormal findings Total Crude Rate 48.4
Males R00 - R99 Symptoms, signs and abnormal findings Total Crude Rate 43.8
Females R00 - R99 Symptoms, signs and abnormal findings Total Crude Rate 52.8
Persons S00 - T98 Injury poisoning and other external causes 0-14 Age Specific Rate 23.4
Persons S00 - T98 Injury poisoning and other external causes 15-29 Age Specific Rate 35.3
Persons S00 - T98 Injury poisoning and other external causes 30-44 Age Specific Rate 29.3
Persons S00 - T98 Injury poisoning and other external causes 45-64 Age Specific Rate 34.0
Persons S00 - T98 Injury poisoning and other external causes 65+ Age Specific Rate 85.6
Males S00 - T98 Injury poisoning and other external causes 0-14 Age Specific Rate 27.2
Males S00 - T98 Injury poisoning and other external causes 15-29 Age Specific Rate 41.8
Males S00 - T98 Injury poisoning and other external causes 30-44 Age Specific Rate 34.9
Males S00 - T98 Injury poisoning and other external causes 45-64 Age Specific Rate 37.0
Males S00 - T98 Injury poisoning and other external causes 65+ Age Specific Rate 80.1
Females S00 - T98 Injury poisoning and other external causes 0-14 Age Specific Rate 19.4
Females S00 - T98 Injury poisoning and other external causes 15-29 Age Specific Rate 28.7
Females S00 - T98 Injury poisoning and other external causes 30-44 Age Specific Rate 23.9
Females S00 - T98 Injury poisoning and other external causes 45-64 Age Specific Rate 31.1
Females S00 - T98 Injury poisoning and other external causes 65+ Age Specific Rate 90.7
Persons S00 - T98 Injury poisoning and other external causes Total Age Standardised Rate 37.6
Males S00 - T98 Injury poisoning and other external causes Total Age Standardised Rate 41.4
Females S00 - T98 Injury poisoning and other external causes Total Age Standardised Rate 33.7
Persons S00 - T98 Injury poisoning and other external causes Total Crude Rate 39.6
Males S00 - T98 Injury poisoning and other external causes Total Crude Rate 42.2
Females S00 - T98 Injury poisoning and other external causes Total Crude Rate 36.9
Persons Z00 - Z99 Factors influencing health status and contact with health services 0-14 Age Specific Rate 14.0
Persons Z00 - Z99 Factors influencing health status and contact with health services 15-29 Age Specific Rate 25.3
Persons Z00 - Z99 Factors influencing health status and contact with health services 30-44 Age Specific Rate 69.0
Persons Z00 - Z99 Factors influencing health status and contact with health services 45-64 Age Specific Rate 177.9
Persons Z00 - Z99 Factors influencing health status and contact with health services 65+ Age Specific Rate 408.5
Males Z00 - Z99 Factors influencing health status and contact with health services 0-14 Age Specific Rate 14.7
Males Z00 - Z99 Factors influencing health status and contact with health services 15-29 Age Specific Rate 18.2
Males Z00 - Z99 Factors influencing health status and contact with health services 30-44 Age Specific Rate 46.8
Males Z00 - Z99 Factors influencing health status and contact with health services 45-64 Age Specific Rate 184.4
Males Z00 - Z99 Factors influencing health status and contact with health services 65+ Age Specific Rate 511.0
Females Z00 - Z99 Factors influencing health status and contact with health services 0-14 Age Specific Rate 13.2
Females Z00 - Z99 Factors influencing health status and contact with health services 15-29 Age Specific Rate 32.5
Females Z00 - Z99 Factors influencing health status and contact with health services 30-44 Age Specific Rate 90.3
Females Z00 - Z99 Factors influencing health status and contact with health services 45-64 Age Specific Rate 171.7
Females Z00 - Z99 Factors influencing health status and contact with health services 65+ Age Specific Rate 315.7
Persons Z00 - Z99 Factors influencing health status and contact with health services Total Age Standardised Rate 115.4
Males Z00 - Z99 Factors influencing health status and contact with health services Total Age Standardised Rate 123.4
Females Z00 - Z99 Factors influencing health status and contact with health services Total Age Standardised Rate 108.7
Persons Z00 - Z99 Factors influencing health status and contact with health services Total Crude Rate 131.1
Males Z00 - Z99 Factors influencing health status and contact with health services Total Crude Rate 139.8
Females Z00 - Z99 Factors influencing health status and contact with health services Total Crude Rate 122.6

Trends

Trends in admitted episodes of care are presented below, however, changes in hospital admission practices and diagnoses coding rules over time mean that results should be viewed with caution.3–7

Changes in standardised rates for admitted episodes of care include:

  • Factors influencing health status and contact with health services increased by 44.0% from 2002–03 to 2020–21, with standardised rates increasing from 80.1 to 115.4 per 1,000 persons.
  • Similarly, Symptoms, signs and abnormal findings increased more than two-fold from 19.9 to 44.9 per 1,000 persons.
  • Mental and behavioural disorders increased steadily from 2007–08 across all age groups except children.
  • Diseases of respiratory system decreased between 2018–2019 and 2020–21. Changes in hospital admission practice during the COVID-19 pandemic and lower numbers of influenza and other respiratory infections were key factors.
Figure 3: Queensland trends in hospital admission rates by ICD chapter

Remoteness and socioeconomic differences

Differences in standardised hospitalisation rates between geographic areas are complex and are impacted by multiple factors such as:

  • differences in underlying patterns of disease and injury
  • the number of hospitalisations needed to treat health conditions
  • the availability and accessibility of healthcare locally.

Results should be interpreted as broad patterns that may indicate a need for further analysis. Such analysis, such as adjusting for repeated admissions for a single person, would provide more specific insights for specific conditions.

In 2020–21, people living in remote and very remote areas of Queensland had higher hospitalisation rates. Standardised rates in remote and very remote areas were 620.1 per 1,000 persons in 2020–21 but ranged from 493.3 to 516.2 in major cities and regional areas (Figure 4).

Differences in standardised rates for specific ICD chapters include:

  • Factors influencing health status and contact with health services—199.1 per 1,000 persons in remote and very remote areas compared to 111.4 per 1,000 persons in major cities
  • Injury poisoning and other external causes—58.7 per 1,000 persons in remote and very remote areas compared to 36.1 per 1,000 persons in major cities.

Conversely, the rate for Mental and behavioural disorders was nearly twice as high in the major cities area compared to remote and very remote areas. Under the ICD coding system, Mental and behavioural disorders includes dementia and Alzheimer’s disease which should be considered in interpreting these results.

Similar patterns were seen between areas with different socioeconomic profiles. Queenslanders living in the most disadvantage areas had the highest standardised hospitalisation rates for Factors influencing health status and contact with health services and Injury poisoning and other external causes while rates for Mental and behavioural disorders were highest among those people living in the most advantaged areas (Figure 4).

Figure 4: All cause hospitalisation rates by remoteness and socioeconomic status, 2020–21

Figure 4a: All cause hospitalisation rates by remoteness and socioeconomic status, 2020–21 (all cause)
Bar graph showing the age standardised rates by remoteness area and SEIFA for 2020-21 for all cause, showing higher rates for remote and socioeconomically disadvantaged areas
Figure 4b: All cause hospitalisation rates by remoteness and socioeconomic status, 2020–21 (mental health)
Bar graph showing the age standardised rates by remoteness area and SEIFA for 2020-21 for ICD-10-AM chapter Mental and behavioural disorders, showing higher rates for urban and socioeconomically advantaged areas
Figure 4c: All cause hospitalisation rates by remoteness and socioeconomic status, 2020–21 (injury)
Bar graph showing the age standardised rates by remoteness area and SEIFA for 2020-21 for injury, poisoning and other consequences of external causes, showing higher rates for remote and socioeconomically disadvantaged areas
Figure 4d: All cause hospitalisation rates by remoteness and socioeconomic status, 2020–21 (circulatory)
Bar graph showing the age standardised rates by remoteness area and SEIFA for 2020-21 for diseases of the circulatory system, showing higher rates for remote and socioeconomically disadvantaged areas
Figure 4e: All cause hospitalisation rates by remoteness and socioeconomic status, 2020–21 (respiratory)
Bar graph showing the age standardised rates by remoteness area and SEIFA for 2020-21 for diseases of the circulatory system, showing higher rates for remote and socioeconomically disadvantaged areas
Figure 4f: All cause hospitalisation rates by remoteness and socioeconomic status, 2020–21 (health status factors)
Bar graph showing the age standardised rates by remoteness area and SEIFA for 2020-21 for factors influencing health status and contact with health services, showing higher rates for remote and socioeconomically disadvantaged areas
Figure 4g: All cause hospitalisation rates by remoteness and socioeconomic status, 2020–21 (symptoms and findings)
Bar graph showing the age standardised rates by remoteness area and SEIFA for2020-21for symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified, showing higher rates for socioeconomically disadvantaged areas
Figure 4h: All cause hospitalisation rates by remoteness and socioeconomic status, 2020–21 (table)
Area classification Area categoryConditionType Rate per 1,000
SEIFA Most disadvantaged A00 - B99 Infectious and parasitic diseases Crude Rate 10.6
SEIFA Most disadvantaged A00 - B99 Infectious and parasitic diseases Age Standardised Rate 9.5
SEIFA Q2 A00 - B99 Infectious and parasitic diseases Crude Rate 9.8
SEIFA Q2 A00 - B99 Infectious and parasitic diseases Age Standardised Rate 8.8
SEIFA Q3 A00 - B99 Infectious and parasitic diseases Crude Rate 7.6
SEIFA Q3 A00 - B99 Infectious and parasitic diseases Age Standardised Rate 7.3
SEIFA Q4 A00 - B99 Infectious and parasitic diseases Crude Rate 7.1
SEIFA Q4 A00 - B99 Infectious and parasitic diseases Age Standardised Rate 6.9
SEIFA Most advantaged A00 - B99 Infectious and parasitic diseases Crude Rate 6.0
SEIFA Most advantaged A00 - B99 Infectious and parasitic diseases Age Standardised Rate 6.0
SEIFA Most disadvantaged All cause (A00-Z99) Crude Rate 638.4
SEIFA Most disadvantaged All cause (A00-Z99) Age Standardised Rate 564.2
SEIFA Q2 All cause (A00-Z99) Crude Rate 590.3
SEIFA Q2 All cause (A00-Z99) Age Standardised Rate 517.1
SEIFA Q3 All cause (A00-Z99) Crude Rate 532.4
SEIFA Q3 All cause (A00-Z99) Age Standardised Rate 499.2
SEIFA Q4 All cause (A00-Z99) Crude Rate 522.3
SEIFA Q4 All cause (A00-Z99) Age Standardised Rate 495.9
SEIFA Most advantaged All cause (A00-Z99) Crude Rate 485.8
SEIFA Most advantaged All cause (A00-Z99) Age Standardised Rate 473.7
SEIFA Most disadvantaged C00 - C97 Malignant neoplasms Crude Rate 22.4
SEIFA Most disadvantaged C00 - C97 Malignant neoplasms Age Standardised Rate 16.9
SEIFA Q2 C00 - C97 Malignant neoplasms Crude Rate 22.2
SEIFA Q2 C00 - C97 Malignant neoplasms Age Standardised Rate 16.9
SEIFA Q3 C00 - C97 Malignant neoplasms Crude Rate 19.6
SEIFA Q3 C00 - C97 Malignant neoplasms Age Standardised Rate 17.1
SEIFA Q4 C00 - C97 Malignant neoplasms Crude Rate 19.3
SEIFA Q4 C00 - C97 Malignant neoplasms Age Standardised Rate 17.4
SEIFA Most advantaged C00 - C97 Malignant neoplasms Crude Rate 20.1
SEIFA Most advantaged C00 - C97 Malignant neoplasms Age Standardised Rate 19.4
SEIFA Most disadvantaged D00 - D48 Benign and other neoplasms Crude Rate 14.1
SEIFA Most disadvantaged D00 - D48 Benign and other neoplasms Age Standardised Rate 11.4
SEIFA Q2 D00 - D48 Benign and other neoplasms Crude Rate 14.2
SEIFA Q2 D00 - D48 Benign and other neoplasms Age Standardised Rate 11.6
SEIFA Q3 D00 - D48 Benign and other neoplasms Crude Rate 13.9
SEIFA Q3 D00 - D48 Benign and other neoplasms Age Standardised Rate 12.6
SEIFA Q4 D00 - D48 Benign and other neoplasms Crude Rate 14.4
SEIFA Q4 D00 - D48 Benign and other neoplasms Age Standardised Rate 13.4
SEIFA Most advantaged D00 - D48 Benign and other neoplasms Crude Rate 16.8
SEIFA Most advantaged D00 - D48 Benign and other neoplasms Age Standardised Rate 16.2
SEIFA Most disadvantaged D50 - D89 Diseases of blood and blood forming organs etc Crude Rate 11.2
SEIFA Most disadvantaged D50 - D89 Diseases of blood and blood forming organs etc Age Standardised Rate 9.2
SEIFA Q2 D50 - D89 Diseases of blood and blood forming organs etc Crude Rate 11.8
SEIFA Q2 D50 - D89 Diseases of blood and blood forming organs etc Age Standardised Rate 9.6
SEIFA Q3 D50 - D89 Diseases of blood and blood forming organs etc Crude Rate 10.1
SEIFA Q3 D50 - D89 Diseases of blood and blood forming organs etc Age Standardised Rate 9.1
SEIFA Q4 D50 - D89 Diseases of blood and blood forming organs etc Crude Rate 10.8
SEIFA Q4 D50 - D89 Diseases of blood and blood forming organs etc Age Standardised Rate 10.1
SEIFA Most advantaged D50 - D89 Diseases of blood and blood forming organs etc Crude Rate 10.4
SEIFA Most advantaged D50 - D89 Diseases of blood and blood forming organs etc Age Standardised Rate 10.1
SEIFA Most disadvantaged E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Crude Rate 12.6
SEIFA Most disadvantaged E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Age Standardised Rate 11.7
SEIFA Q2 E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Crude Rate 11.1
SEIFA Q2 E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Age Standardised Rate 10.1
SEIFA Q3 E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Crude Rate 10.3
SEIFA Q3 E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Age Standardised Rate 9.9
SEIFA Q4 E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Crude Rate 9.7
SEIFA Q4 E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Age Standardised Rate 9.4
SEIFA Most advantaged E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Crude Rate 8.4
SEIFA Most advantaged E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Age Standardised Rate 8.2
SEIFA Most disadvantaged F00 - F99 Mental and behavioural disorders Crude Rate 22.2
SEIFA Most disadvantaged F00 - F99 Mental and behavioural disorders Age Standardised Rate 22.9
SEIFA Q2 F00 - F99 Mental and behavioural disorders Crude Rate 22.0
SEIFA Q2 F00 - F99 Mental and behavioural disorders Age Standardised Rate 21.8
SEIFA Q3 F00 - F99 Mental and behavioural disorders Crude Rate 24.5
SEIFA Q3 F00 - F99 Mental and behavioural disorders Age Standardised Rate 24.3
SEIFA Q4 F00 - F99 Mental and behavioural disorders Crude Rate 29.8
SEIFA Q4 F00 - F99 Mental and behavioural disorders Age Standardised Rate 29.5
SEIFA Most advantaged F00 - F99 Mental and behavioural disorders Crude Rate 37.2
SEIFA Most advantaged F00 - F99 Mental and behavioural disorders Age Standardised Rate 36.0
SEIFA Most disadvantaged G00 - G99 Nervous system and sense organ disorders Crude Rate 17.1
SEIFA Most disadvantaged G00 - G99 Nervous system and sense organ disorders Age Standardised Rate 15.5
SEIFA Q2 G00 - G99 Nervous system and sense organ disorders Crude Rate 17.1
SEIFA Q2 G00 - G99 Nervous system and sense organ disorders Age Standardised Rate 15.3
SEIFA Q3 G00 - G99 Nervous system and sense organ disorders Crude Rate 15.7
SEIFA Q3 G00 - G99 Nervous system and sense organ disorders Age Standardised Rate 14.8
SEIFA Q4 G00 - G99 Nervous system and sense organ disorders Crude Rate 16.1
SEIFA Q4 G00 - G99 Nervous system and sense organ disorders Age Standardised Rate 15.3
SEIFA Most advantaged G00 - G99 Nervous system and sense organ disorders Crude Rate 17.3
SEIFA Most advantaged G00 - G99 Nervous system and sense organ disorders Age Standardised Rate 16.9
SEIFA Most disadvantaged H00 - H59 Diseases of eye and adnexa Crude Rate 25.0
SEIFA Most disadvantaged H00 - H59 Diseases of eye and adnexa Age Standardised Rate 18.1
SEIFA Q2 H00 - H59 Diseases of eye and adnexa Crude Rate 24.4
SEIFA Q2 H00 - H59 Diseases of eye and adnexa Age Standardised Rate 17.8
SEIFA Q3 H00 - H59 Diseases of eye and adnexa Crude Rate 21.9
SEIFA Q3 H00 - H59 Diseases of eye and adnexa Age Standardised Rate 18.9
SEIFA Q4 H00 - H59 Diseases of eye and adnexa Crude Rate 20.9
SEIFA Q4 H00 - H59 Diseases of eye and adnexa Age Standardised Rate 18.7
SEIFA Most advantaged H00 - H59 Diseases of eye and adnexa Crude Rate 19.9
SEIFA Most advantaged H00 - H59 Diseases of eye and adnexa Age Standardised Rate 19.2
SEIFA Most disadvantaged H60 - H95 Diseases of ear and mastoid process Crude Rate 4.0
SEIFA Most disadvantaged H60 - H95 Diseases of ear and mastoid process Age Standardised Rate 3.7
SEIFA Q2 H60 - H95 Diseases of ear and mastoid process Crude Rate 3.4
SEIFA Q2 H60 - H95 Diseases of ear and mastoid process Age Standardised Rate 3.1
SEIFA Q3 H60 - H95 Diseases of ear and mastoid process Crude Rate 3.6
SEIFA Q3 H60 - H95 Diseases of ear and mastoid process Age Standardised Rate 3.5
SEIFA Q4 H60 - H95 Diseases of ear and mastoid process Crude Rate 3.5
SEIFA Q4 H60 - H95 Diseases of ear and mastoid process Age Standardised Rate 3.4
SEIFA Most advantaged H60 - H95 Diseases of ear and mastoid process Crude Rate 3.0
SEIFA Most advantaged H60 - H95 Diseases of ear and mastoid process Age Standardised Rate 3.1
SEIFA Most disadvantaged I00 - I99 Diseases of circulatory system Crude Rate 33.8
SEIFA Most disadvantaged I00 - I99 Diseases of circulatory system Age Standardised Rate 26.1
SEIFA Q2 I00 - I99 Diseases of circulatory system Crude Rate 30.6
SEIFA Q2 I00 - I99 Diseases of circulatory system Age Standardised Rate 23.5
SEIFA Q3 I00 - I99 Diseases of circulatory system Crude Rate 25.1
SEIFA Q3 I00 - I99 Diseases of circulatory system Age Standardised Rate 22.1
SEIFA Q4 I00 - I99 Diseases of circulatory system Crude Rate 23.6
SEIFA Q4 I00 - I99 Diseases of circulatory system Age Standardised Rate 21.3
SEIFA Most advantaged I00 - I99 Diseases of circulatory system Crude Rate 20.8
SEIFA Most advantaged I00 - I99 Diseases of circulatory system Age Standardised Rate 20.0
SEIFA Most disadvantaged J00 - J99 Diseases of respiratory system Crude Rate 24.3
SEIFA Most disadvantaged J00 - J99 Diseases of respiratory system Age Standardised Rate 21.5
SEIFA Q2 J00 - J99 Diseases of respiratory system Crude Rate 21.1
SEIFA Q2 J00 - J99 Diseases of respiratory system Age Standardised Rate 19.1
SEIFA Q3 J00 - J99 Diseases of respiratory system Crude Rate 18.3
SEIFA Q3 J00 - J99 Diseases of respiratory system Age Standardised Rate 17.6
SEIFA Q4 J00 - J99 Diseases of respiratory system Crude Rate 17.6
SEIFA Q4 J00 - J99 Diseases of respiratory system Age Standardised Rate 17.2
SEIFA Most advantaged J00 - J99 Diseases of respiratory system Crude Rate 14.1
SEIFA Most advantaged J00 - J99 Diseases of respiratory system Age Standardised Rate 14.5
SEIFA Most disadvantaged K00 - K93 Diseases of the digestive system Crude Rate 52.9
SEIFA Most disadvantaged K00 - K93 Diseases of the digestive system Age Standardised Rate 48.9
SEIFA Q2 K00 - K93 Diseases of the digestive system Crude Rate 53.6
SEIFA Q2 K00 - K93 Diseases of the digestive system Age Standardised Rate 49.0
SEIFA Q3 K00 - K93 Diseases of the digestive system Crude Rate 52.4
SEIFA Q3 K00 - K93 Diseases of the digestive system Age Standardised Rate 50.0
SEIFA Q4 K00 - K93 Diseases of the digestive system Crude Rate 51.1
SEIFA Q4 K00 - K93 Diseases of the digestive system Age Standardised Rate 49.3
SEIFA Most advantaged K00 - K93 Diseases of the digestive system Crude Rate 49.4
SEIFA Most advantaged K00 - K93 Diseases of the digestive system Age Standardised Rate 48.1
SEIFA Most disadvantaged L00 - L99 Diseases of skin and subcutaneous tissue Crude Rate 12.4
SEIFA Most disadvantaged L00 - L99 Diseases of skin and subcutaneous tissue Age Standardised Rate 11.8
SEIFA Q2 L00 - L99 Diseases of skin and subcutaneous tissue Crude Rate 10.3
SEIFA Q2 L00 - L99 Diseases of skin and subcutaneous tissue Age Standardised Rate 9.5
SEIFA Q3 L00 - L99 Diseases of skin and subcutaneous tissue Crude Rate 8.0
SEIFA Q3 L00 - L99 Diseases of skin and subcutaneous tissue Age Standardised Rate 7.7
SEIFA Q4 L00 - L99 Diseases of skin and subcutaneous tissue Crude Rate 7.3
SEIFA Q4 L00 - L99 Diseases of skin and subcutaneous tissue Age Standardised Rate 7.1
SEIFA Most advantaged L00 - L99 Diseases of skin and subcutaneous tissue Crude Rate 6.5
SEIFA Most advantaged L00 - L99 Diseases of skin and subcutaneous tissue Age Standardised Rate 6.4
SEIFA Most disadvantaged M00 - M99 Diseases of musculoskeletal system and connective tissue Crude Rate 33.2
SEIFA Most disadvantaged M00 - M99 Diseases of musculoskeletal system and connective tissue Age Standardised Rate 28.2
SEIFA Q2 M00 - M99 Diseases of musculoskeletal system and connective tissue Crude Rate 34.7
SEIFA Q2 M00 - M99 Diseases of musculoskeletal system and connective tissue Age Standardised Rate 28.7
SEIFA Q3 M00 - M99 Diseases of musculoskeletal system and connective tissue Crude Rate 33.7
SEIFA Q3 M00 - M99 Diseases of musculoskeletal system and connective tissue Age Standardised Rate 30.8
SEIFA Q4 M00 - M99 Diseases of musculoskeletal system and connective tissue Crude Rate 33.5
SEIFA Q4 M00 - M99 Diseases of musculoskeletal system and connective tissue Age Standardised Rate 31.2
SEIFA Most advantaged M00 - M99 Diseases of musculoskeletal system and connective tissue Crude Rate 30.2
SEIFA Most advantaged M00 - M99 Diseases of musculoskeletal system and connective tissue Age Standardised Rate 29.2
SEIFA Most disadvantaged N00 - N99 Diseases of the genitourinary system Crude Rate 27.8
SEIFA Most disadvantaged N00 - N99 Diseases of the genitourinary system Age Standardised Rate 26.0
SEIFA Q2 N00 - N99 Diseases of the genitourinary system Crude Rate 25.9
SEIFA Q2 N00 - N99 Diseases of the genitourinary system Age Standardised Rate 23.9
SEIFA Q3 N00 - N99 Diseases of the genitourinary system Crude Rate 24.9
SEIFA Q3 N00 - N99 Diseases of the genitourinary system Age Standardised Rate 24.2
SEIFA Q4 N00 - N99 Diseases of the genitourinary system Crude Rate 24.8
SEIFA Q4 N00 - N99 Diseases of the genitourinary system Age Standardised Rate 24.1
SEIFA Most advantaged N00 - N99 Diseases of the genitourinary system Crude Rate 22.1
SEIFA Most advantaged N00 - N99 Diseases of the genitourinary system Age Standardised Rate 21.6
SEIFA Most disadvantaged O00 - O99 Pregnancy, childbirth and puerperium Crude Rate 31.7
SEIFA Most disadvantaged O00 - O99 Pregnancy, childbirth and puerperium Age Standardised Rate 36.7
SEIFA Q2 O00 - O99 Pregnancy, childbirth and puerperium Crude Rate 29.4
SEIFA Q2 O00 - O99 Pregnancy, childbirth and puerperium Age Standardised Rate 34.2
SEIFA Q3 O00 - O99 Pregnancy, childbirth and puerperium Crude Rate 32.6
SEIFA Q3 O00 - O99 Pregnancy, childbirth and puerperium Age Standardised Rate 34.5
SEIFA Q4 O00 - O99 Pregnancy, childbirth and puerperium Crude Rate 30.5
SEIFA Q4 O00 - O99 Pregnancy, childbirth and puerperium Age Standardised Rate 31.6
SEIFA Most advantaged O00 - O99 Pregnancy, childbirth and puerperium Crude Rate 23.3
SEIFA Most advantaged O00 - O99 Pregnancy, childbirth and puerperium Age Standardised Rate 22.5
SEIFA Most disadvantaged P00 - P96 Conditions originating in perinatal period Crude Rate 3.6
SEIFA Most disadvantaged P00 - P96 Conditions originating in perinatal period Age Standardised Rate 3.6
SEIFA Q2 P00 - P96 Conditions originating in perinatal period Crude Rate 3.3
SEIFA Q2 P00 - P96 Conditions originating in perinatal period Age Standardised Rate 3.5
SEIFA Q3 P00 - P96 Conditions originating in perinatal period Crude Rate 3.2
SEIFA Q3 P00 - P96 Conditions originating in perinatal period Age Standardised Rate 3.3
SEIFA Q4 P00 - P96 Conditions originating in perinatal period Crude Rate 3.0
SEIFA Q4 P00 - P96 Conditions originating in perinatal period Age Standardised Rate 3.2
SEIFA Most advantaged P00 - P96 Conditions originating in perinatal period Crude Rate 2.4
SEIFA Most advantaged P00 - P96 Conditions originating in perinatal period Age Standardised Rate 3.0
SEIFA Most disadvantaged Q00 - Q99 Congenital anomalies Crude Rate 1.8
SEIFA Most disadvantaged Q00 - Q99 Congenital anomalies Age Standardised Rate 1.8
SEIFA Q2 Q00 - Q99 Congenital anomalies Crude Rate 1.7
SEIFA Q2 Q00 - Q99 Congenital anomalies Age Standardised Rate 1.8
SEIFA Q3 Q00 - Q99 Congenital anomalies Crude Rate 1.7
SEIFA Q3 Q00 - Q99 Congenital anomalies Age Standardised Rate 1.8
SEIFA Q4 Q00 - Q99 Congenital anomalies Crude Rate 1.8
SEIFA Q4 Q00 - Q99 Congenital anomalies Age Standardised Rate 1.8
SEIFA Most advantaged Q00 - Q99 Congenital anomalies Crude Rate 1.6
SEIFA Most advantaged Q00 - Q99 Congenital anomalies Age Standardised Rate 1.8
SEIFA Most disadvantaged R00 - R99 Symptoms, signs and abnormal findings Crude Rate 55.5
SEIFA Most disadvantaged R00 - R99 Symptoms, signs and abnormal findings Age Standardised Rate 50.4
SEIFA Q2 R00 - R99 Symptoms, signs and abnormal findings Crude Rate 51.8
SEIFA Q2 R00 - R99 Symptoms, signs and abnormal findings Age Standardised Rate 45.9
SEIFA Q3 R00 - R99 Symptoms, signs and abnormal findings Crude Rate 48.1
SEIFA Q3 R00 - R99 Symptoms, signs and abnormal findings Age Standardised Rate 45.3
SEIFA Q4 R00 - R99 Symptoms, signs and abnormal findings Crude Rate 46.3
SEIFA Q4 R00 - R99 Symptoms, signs and abnormal findings Age Standardised Rate 44.1
SEIFA Most advantaged R00 - R99 Symptoms, signs and abnormal findings Crude Rate 40.9
SEIFA Most advantaged R00 - R99 Symptoms, signs and abnormal findings Age Standardised Rate 39.9
SEIFA Most disadvantaged S00 - T98 Injury poisoning and other external causes Crude Rate 48.4
SEIFA Most disadvantaged S00 - T98 Injury poisoning and other external causes Age Standardised Rate 45.4
SEIFA Q2 S00 - T98 Injury poisoning and other external causes Crude Rate 45.2
SEIFA Q2 S00 - T98 Injury poisoning and other external causes Age Standardised Rate 42.2
SEIFA Q3 S00 - T98 Injury poisoning and other external causes Crude Rate 38.0
SEIFA Q3 S00 - T98 Injury poisoning and other external causes Age Standardised Rate 36.6
SEIFA Q4 S00 - T98 Injury poisoning and other external causes Crude Rate 35.9
SEIFA Q4 S00 - T98 Injury poisoning and other external causes Age Standardised Rate 34.7
SEIFA Most advantaged S00 - T98 Injury poisoning and other external causes Crude Rate 31.3
SEIFA Most advantaged S00 - T98 Injury poisoning and other external causes Age Standardised Rate 30.9
SEIFA Most disadvantaged Z00 - Z99 Factors influencing health status and contact with health services Crude Rate 174.0
SEIFA Most disadvantaged Z00 - Z99 Factors influencing health status and contact with health services Age Standardised Rate 145.0
SEIFA Q2 Z00 - Z99 Factors influencing health status and contact with health services Crude Rate 146.9
SEIFA Q2 Z00 - Z99 Factors influencing health status and contact with health services Age Standardised Rate 120.7
SEIFA Q3 Z00 - Z99 Factors influencing health status and contact with health services Crude Rate 119.4
SEIFA Q3 Z00 - Z99 Factors influencing health status and contact with health services Age Standardised Rate 107.7
SEIFA Q4 Z00 - Z99 Factors influencing health status and contact with health services Crude Rate 115.4
SEIFA Q4 Z00 - Z99 Factors influencing health status and contact with health services Age Standardised Rate 106.2
SEIFA Most advantaged Z00 - Z99 Factors influencing health status and contact with health services Crude Rate 103.9
SEIFA Most advantaged Z00 - Z99 Factors influencing health status and contact with health services Age Standardised Rate 100.7
Remoteness Major cities A00 - B99 Infectious and parasitic diseases Crude Rate 7.6
Remoteness Major cities A00 - B99 Infectious and parasitic diseases Age Standardised Rate 7.3
Remoteness Inner regional A00 - B99 Infectious and parasitic diseases Crude Rate 9.4
Remoteness Inner regional A00 - B99 Infectious and parasitic diseases Age Standardised Rate 8.2
Remoteness Outer regional A00 - B99 Infectious and parasitic diseases Crude Rate 8.5
Remoteness Outer regional A00 - B99 Infectious and parasitic diseases Age Standardised Rate 8.0
Remoteness Remote and very remote A00 - B99 Infectious and parasitic diseases Crude Rate 12.2
Remoteness Remote and very remote A00 - B99 Infectious and parasitic diseases Age Standardised Rate 12.1
Remoteness Major cities All cause (A00-Z99) Crude Rate 540.1
Remoteness Major cities All cause (A00-Z99) Age Standardised Rate 508.0
Remoteness Inner regional All cause (A00-Z99) Crude Rate 574.5
Remoteness Inner regional All cause (A00-Z99) Age Standardised Rate 493.3
Remoteness Outer regional All cause (A00-Z99) Crude Rate 566.4
Remoteness Outer regional All cause (A00-Z99) Age Standardised Rate 516.2
Remoteness Remote and very remote All cause (A00-Z99) Crude Rate 617.4
Remoteness Remote and very remote All cause (A00-Z99) Age Standardised Rate 620.1
Remoteness Major cities C00 - C97 Malignant neoplasms Crude Rate 20.1
Remoteness Major cities C00 - C97 Malignant neoplasms Age Standardised Rate 17.9
Remoteness Inner regional C00 - C97 Malignant neoplasms Crude Rate 23.2
Remoteness Inner regional C00 - C97 Malignant neoplasms Age Standardised Rate 16.7
Remoteness Outer regional C00 - C97 Malignant neoplasms Crude Rate 20.4
Remoteness Outer regional C00 - C97 Malignant neoplasms Age Standardised Rate 16.7
Remoteness Remote and very remote C00 - C97 Malignant neoplasms Crude Rate 15.8
Remoteness Remote and very remote C00 - C97 Malignant neoplasms Age Standardised Rate 15.6
Remoteness Major cities D00 - D48 Benign and other neoplasms Crude Rate 14.8
Remoteness Major cities D00 - D48 Benign and other neoplasms Age Standardised Rate 13.6
Remoteness Inner regional D00 - D48 Benign and other neoplasms Crude Rate 16.2
Remoteness Inner regional D00 - D48 Benign and other neoplasms Age Standardised Rate 12.7
Remoteness Outer regional D00 - D48 Benign and other neoplasms Crude Rate 13.0
Remoteness Outer regional D00 - D48 Benign and other neoplasms Age Standardised Rate 11.2
Remoteness Remote and very remote D00 - D48 Benign and other neoplasms Crude Rate 8.5
Remoteness Remote and very remote D00 - D48 Benign and other neoplasms Age Standardised Rate 8.3
Remoteness Major cities D50 - D89 Diseases of blood and blood forming organs etc Crude Rate 11.1
Remoteness Major cities D50 - D89 Diseases of blood and blood forming organs etc Age Standardised Rate 10.1
Remoteness Inner regional D50 - D89 Diseases of blood and blood forming organs etc Crude Rate 11.7
Remoteness Inner regional D50 - D89 Diseases of blood and blood forming organs etc Age Standardised Rate 9.2
Remoteness Outer regional D50 - D89 Diseases of blood and blood forming organs etc Crude Rate 9.1
Remoteness Outer regional D50 - D89 Diseases of blood and blood forming organs etc Age Standardised Rate 8.0
Remoteness Remote and very remote D50 - D89 Diseases of blood and blood forming organs etc Crude Rate 7.3
Remoteness Remote and very remote D50 - D89 Diseases of blood and blood forming organs etc Age Standardised Rate 7.6
Remoteness Major cities E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Crude Rate 10.0
Remoteness Major cities E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Age Standardised Rate 9.6
Remoteness Inner regional E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Crude Rate 10.9
Remoteness Inner regional E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Age Standardised Rate 10.0
Remoteness Outer regional E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Crude Rate 10.7
Remoteness Outer regional E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Age Standardised Rate 10.0
Remoteness Remote and very remote E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Crude Rate 14.7
Remoteness Remote and very remote E00 - E89/E90 Endocrine, nutritional and metabolic disorders including diabetes Age Standardised Rate 14.9
Remoteness Major cities F00 - F99 Mental and behavioural disorders Crude Rate 33.0
Remoteness Major cities F00 - F99 Mental and behavioural disorders Age Standardised Rate 32.3
Remoteness Inner regional F00 - F99 Mental and behavioural disorders Crude Rate 16.0
Remoteness Inner regional F00 - F99 Mental and behavioural disorders Age Standardised Rate 16.2
Remoteness Outer regional F00 - F99 Mental and behavioural disorders Crude Rate 18.7
Remoteness Outer regional F00 - F99 Mental and behavioural disorders Age Standardised Rate 19.1
Remoteness Remote and very remote F00 - F99 Mental and behavioural disorders Crude Rate 16.2
Remoteness Remote and very remote F00 - F99 Mental and behavioural disorders Age Standardised Rate 17.4
Remoteness Major cities G00 - G99 Nervous system and sense organ disorders Crude Rate 16.7
Remoteness Major cities G00 - G99 Nervous system and sense organ disorders Age Standardised Rate 15.9
Remoteness Inner regional G00 - G99 Nervous system and sense organ disorders Crude Rate 17.6
Remoteness Inner regional G00 - G99 Nervous system and sense organ disorders Age Standardised Rate 15.3
Remoteness Outer regional G00 - G99 Nervous system and sense organ disorders Crude Rate 15.4
Remoteness Outer regional G00 - G99 Nervous system and sense organ disorders Age Standardised Rate 14.2
Remoteness Remote and very remote G00 - G99 Nervous system and sense organ disorders Crude Rate 11.6
Remoteness Remote and very remote G00 - G99 Nervous system and sense organ disorders Age Standardised Rate 11.7
Remoteness Major cities H00 - H59 Diseases of eye and adnexa Crude Rate 22.8
Remoteness Major cities H00 - H59 Diseases of eye and adnexa Age Standardised Rate 20.0
Remoteness Inner regional H00 - H59 Diseases of eye and adnexa Crude Rate 24.2
Remoteness Inner regional H00 - H59 Diseases of eye and adnexa Age Standardised Rate 16.6
Remoteness Outer regional H00 - H59 Diseases of eye and adnexa Crude Rate 19.0
Remoteness Outer regional H00 - H59 Diseases of eye and adnexa Age Standardised Rate 15.3
Remoteness Remote and very remote H00 - H59 Diseases of eye and adnexa Crude Rate 14.6
Remoteness Remote and very remote H00 - H59 Diseases of eye and adnexa Age Standardised Rate 14.3
Remoteness Major cities H60 - H95 Diseases of ear and mastoid process Crude Rate 3.7
Remoteness Major cities H60 - H95 Diseases of ear and mastoid process Age Standardised Rate 3.6
Remoteness Inner regional H60 - H95 Diseases of ear and mastoid process Crude Rate 3.2
Remoteness Inner regional H60 - H95 Diseases of ear and mastoid process Age Standardised Rate 2.9
Remoteness Outer regional H60 - H95 Diseases of ear and mastoid process Crude Rate 2.9
Remoteness Outer regional H60 - H95 Diseases of ear and mastoid process Age Standardised Rate 2.7
Remoteness Remote and very remote H60 - H95 Diseases of ear and mastoid process Crude Rate 3.7
Remoteness Remote and very remote H60 - H95 Diseases of ear and mastoid process Age Standardised Rate 3.5
Remoteness Major cities I00 - I99 Diseases of circulatory system Crude Rate 24.4
Remoteness Major cities I00 - I99 Diseases of circulatory system Age Standardised Rate 21.6
Remoteness Inner regional I00 - I99 Diseases of circulatory system Crude Rate 33.8
Remoteness Inner regional I00 - I99 Diseases of circulatory system Age Standardised Rate 24.7
Remoteness Outer regional I00 - I99 Diseases of circulatory system Crude Rate 26.6
Remoteness Outer regional I00 - I99 Diseases of circulatory system Age Standardised Rate 22.5
Remoteness Remote and very remote I00 - I99 Diseases of circulatory system Crude Rate 29.2
Remoteness Remote and very remote I00 - I99 Diseases of circulatory system Age Standardised Rate 30.0
Remoteness Major cities J00 - J99 Diseases of respiratory system Crude Rate 18.2
Remoteness Major cities J00 - J99 Diseases of respiratory system Age Standardised Rate 17.7
Remoteness Inner regional J00 - J99 Diseases of respiratory system Crude Rate 20.5
Remoteness Inner regional J00 - J99 Diseases of respiratory system Age Standardised Rate 18.2
Remoteness Outer regional J00 - J99 Diseases of respiratory system Crude Rate 19.1
Remoteness Outer regional J00 - J99 Diseases of respiratory system Age Standardised Rate 17.9
Remoteness Remote and very remote J00 - J99 Diseases of respiratory system Crude Rate 27.1
Remoteness Remote and very remote J00 - J99 Diseases of respiratory system Age Standardised Rate 26.4
Remoteness Major cities K00 - K93 Diseases of the digestive system Crude Rate 49.9
Remoteness Major cities K00 - K93 Diseases of the digestive system Age Standardised Rate 47.9
Remoteness Inner regional K00 - K93 Diseases of the digestive system Crude Rate 58.6
Remoteness Inner regional K00 - K93 Diseases of the digestive system Age Standardised Rate 53.0
Remoteness Outer regional K00 - K93 Diseases of the digestive system Crude Rate 51.4
Remoteness Outer regional K00 - K93 Diseases of the digestive system Age Standardised Rate 48.3
Remoteness Remote and very remote K00 - K93 Diseases of the digestive system Crude Rate 49.1
Remoteness Remote and very remote K00 - K93 Diseases of the digestive system Age Standardised Rate 50.3
Remoteness Major cities L00 - L99 Diseases of skin and subcutaneous tissue Crude Rate 7.9
Remoteness Major cities L00 - L99 Diseases of skin and subcutaneous tissue Age Standardised Rate 7.6
Remoteness Inner regional L00 - L99 Diseases of skin and subcutaneous tissue Crude Rate 9.9
Remoteness Inner regional L00 - L99 Diseases of skin and subcutaneous tissue Age Standardised Rate 9.0
Remoteness Outer regional L00 - L99 Diseases of skin and subcutaneous tissue Crude Rate 10.8
Remoteness Outer regional L00 - L99 Diseases of skin and subcutaneous tissue Age Standardised Rate 10.3
Remoteness Remote and very remote L00 - L99 Diseases of skin and subcutaneous tissue Crude Rate 15.4
Remoteness Remote and very remote L00 - L99 Diseases of skin and subcutaneous tissue Age Standardised Rate 15.9
Remoteness Major cities M00 - M99 Diseases of musculoskeletal system and connective tissue Crude Rate 32.6
Remoteness Major cities M00 - M99 Diseases of musculoskeletal system and connective tissue Age Standardised Rate 30.2
Remoteness Inner regional M00 - M99 Diseases of musculoskeletal system and connective tissue Crude Rate 33.8
Remoteness Inner regional M00 - M99 Diseases of musculoskeletal system and connective tissue Age Standardised Rate 27.4
Remoteness Outer regional M00 - M99 Diseases of musculoskeletal system and connective tissue Crude Rate 35.0
Remoteness Outer regional M00 - M99 Diseases of musculoskeletal system and connective tissue Age Standardised Rate 30.7
Remoteness Remote and very remote M00 - M99 Diseases of musculoskeletal system and connective tissue Crude Rate 24.1
Remoteness Remote and very remote M00 - M99 Diseases of musculoskeletal system and connective tissue Age Standardised Rate 24.3
Remoteness Major cities N00 - N99 Diseases of the genitourinary system Crude Rate 24.6
Remoteness Major cities N00 - N99 Diseases of the genitourinary system Age Standardised Rate 23.8
Remoteness Inner regional N00 - N99 Diseases of the genitourinary system Crude Rate 26.5
Remoteness Inner regional N00 - N99 Diseases of the genitourinary system Age Standardised Rate 24.4
Remoteness Outer regional N00 - N99 Diseases of the genitourinary system Crude Rate 25.2
Remoteness Outer regional N00 - N99 Diseases of the genitourinary system Age Standardised Rate 23.8
Remoteness Remote and very remote N00 - N99 Diseases of the genitourinary system Crude Rate 23.3
Remoteness Remote and very remote N00 - N99 Diseases of the genitourinary system Age Standardised Rate 24.2
Remoteness Major cities O00 - O99 Pregnancy, childbirth and puerperium Crude Rate 30.2
Remoteness Major cities O00 - O99 Pregnancy, childbirth and puerperium Age Standardised Rate 30.2
Remoteness Inner regional O00 - O99 Pregnancy, childbirth and puerperium Crude Rate 26.0
Remoteness Inner regional O00 - O99 Pregnancy, childbirth and puerperium Age Standardised Rate 33.5
Remoteness Outer regional O00 - O99 Pregnancy, childbirth and puerperium Crude Rate 30.5
Remoteness Outer regional O00 - O99 Pregnancy, childbirth and puerperium Age Standardised Rate 34.6
Remoteness Remote and very remote O00 - O99 Pregnancy, childbirth and puerperium Crude Rate 32.1
Remoteness Remote and very remote O00 - O99 Pregnancy, childbirth and puerperium Age Standardised Rate 34.9
Remoteness Major cities P00 - P96 Conditions originating in perinatal period Crude Rate 3.1
Remoteness Major cities P00 - P96 Conditions originating in perinatal period Age Standardised Rate 3.4
Remoteness Inner regional P00 - P96 Conditions originating in perinatal period Crude Rate 3.0
Remoteness Inner regional P00 - P96 Conditions originating in perinatal period Age Standardised Rate 3.4
Remoteness Outer regional P00 - P96 Conditions originating in perinatal period Crude Rate 2.8
Remoteness Outer regional P00 - P96 Conditions originating in perinatal period Age Standardised Rate 3.0
Remoteness Remote and very remote P00 - P96 Conditions originating in perinatal period Crude Rate 3.8
Remoteness Remote and very remote P00 - P96 Conditions originating in perinatal period Age Standardised Rate 3.1
Remoteness Major cities Q00 - Q99 Congenital anomalies Crude Rate 1.7
Remoteness Major cities Q00 - Q99 Congenital anomalies Age Standardised Rate 1.8
Remoteness Inner regional Q00 - Q99 Congenital anomalies Crude Rate 1.6
Remoteness Inner regional Q00 - Q99 Congenital anomalies Age Standardised Rate 1.8
Remoteness Outer regional Q00 - Q99 Congenital anomalies Crude Rate 1.7
Remoteness Outer regional Q00 - Q99 Congenital anomalies Age Standardised Rate 1.8
Remoteness Remote and very remote Q00 - Q99 Congenital anomalies Crude Rate 1.9
Remoteness Remote and very remote Q00 - Q99 Congenital anomalies Age Standardised Rate 1.7
Remoteness Major cities R00 - R99 Symptoms, signs and abnormal findings Crude Rate 48.3
Remoteness Major cities R00 - R99 Symptoms, signs and abnormal findings Age Standardised Rate 45.7
Remoteness Inner regional R00 - R99 Symptoms, signs and abnormal findings Crude Rate 51.8
Remoteness Inner regional R00 - R99 Symptoms, signs and abnormal findings Age Standardised Rate 45.2
Remoteness Outer regional R00 - R99 Symptoms, signs and abnormal findings Crude Rate 44.3
Remoteness Outer regional R00 - R99 Symptoms, signs and abnormal findings Age Standardised Rate 40.7
Remoteness Remote and very remote R00 - R99 Symptoms, signs and abnormal findings Crude Rate 45.3
Remoteness Remote and very remote R00 - R99 Symptoms, signs and abnormal findings Age Standardised Rate 46.2
Remoteness Major cities S00 - T98 Injury poisoning and other external causes Crude Rate 37.7
Remoteness Major cities S00 - T98 Injury poisoning and other external causes Age Standardised Rate 36.1
Remoteness Inner regional S00 - T98 Injury poisoning and other external causes Crude Rate 42.2
Remoteness Inner regional S00 - T98 Injury poisoning and other external causes Age Standardised Rate 39.0
Remoteness Outer regional S00 - T98 Injury poisoning and other external causes Crude Rate 42.2
Remoteness Outer regional S00 - T98 Injury poisoning and other external causes Age Standardised Rate 40.7
Remoteness Remote and very remote S00 - T98 Injury poisoning and other external causes Crude Rate 56.1
Remoteness Remote and very remote S00 - T98 Injury poisoning and other external causes Age Standardised Rate 58.7
Remoteness Major cities Z00 - Z99 Factors influencing health status and contact with health services Crude Rate 121.7
Remoteness Major cities Z00 - Z99 Factors influencing health status and contact with health services Age Standardised Rate 111.4
Remoteness Inner regional Z00 - Z99 Factors influencing health status and contact with health services Crude Rate 134.4
Remoteness Inner regional Z00 - Z99 Factors influencing health status and contact with health services Age Standardised Rate 105.9
Remoteness Outer regional Z00 - Z99 Factors influencing health status and contact with health services Crude Rate 159.4
Remoteness Outer regional Z00 - Z99 Factors influencing health status and contact with health services Age Standardised Rate 136.8
Remoteness Remote and very remote Z00 - Z99 Factors influencing health status and contact with health services Crude Rate 205.4
Remoteness Remote and very remote Z00 - Z99 Factors influencing health status and contact with health services Age Standardised Rate 199.1

Additional information

Data and statistics

More information about Queensland hospitalisations is available from the Queensland Health performance and Statistical Services Branch.

National health statistics are available on the AIHW Admitted patients and Australia’s hospital at glance websites.

Section technical notes

  • Where presented, ratios were calculated using higher precision estimates than those that are displayed within the report.
  • The ICD coding system is maintained by the World Health Organization and provides internationally comparable mortality and morbidity statistics over time and between regions. In Australia, the ICD-10 was adapted for the Australian context from the WHO ICD system. The ICD-10-AM is now maintained by the Independent Health and Aged Care Pricing Authority (IHACPA).5
  • Multiple factors may cause a person’s hospital admission. The principal diagnosis is the one deemed chiefly responsible for the admission.
  • Data reported in this section were sourced from the Queensland Hospital Admitted Patient Data Collection (QHAPDC). Individual records in the QHAPDC are episode based, meaning that multiple episodes from the same person will be counted multiple times in a reporting period.
  • Separations from interstate residents, public psychiatric hospitals and those flagged as unqualified newborns, organ donors or boarders are excluded. Records from 47 previously declared hospitals are excluded.
  • Unless otherwise stated, age-standardised rates were calculated by standardising to 2001 Australian standard population.

References

  1. Queensland Health. 2023. Queensland Hospital Admitted Patient Data Collection (QHAPDC). Accessed: 12 November 2022.
  2. Independent Health and Aged Care Pricing Authority. 2022. ICD-10-AM/ACHI/ACS. Accessed: 4 November 2022.
  3. Queensland Health. 2011. Impact of changes in diabetes coding on Queensland hospital principal diagnosis morbidity data. Accessed: 11 November 2022.
  4. Queensland Health. 2015. Recent growth in public hospital separations – more than meets the eye?. Accessed: 4 November 2022.
  5. Queensland Health. 2018. Impact of changes to coding of rehabilitation episodes of care. Accessed: 4 November 2022.
  6. Queensland Health. 2018. Impact of changes to coding palliative care. Accessed: 4 November 2022.
  7. Queensland Health. 2018. Rehabilitation episodes of care: Top 10 principal diagnosis codes 2014/2015 to 2016/2017. Accessed: 4 November 2022.

Last updated: July 2024